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Abstract
Peppermint oil (PO) and Green Tea oil (GTO) are two essential oils (EOs) were encapsulated
in chitosan nanoparticles (CS NPs) via two-steps method (emulsification followed by ionic
gelation). Encapsulation of GTO and PO in CS NPs were investigated through different
characterization techniques such as; Fourier transform infrared (FT-IR) spectroscopy, powder
X-ray diffraction (XRD). Both NPs (CS/PO NPs and CS/GTO NPs) showed a spherical shape
with 20-90 nm size range as detected by Transmission electron microscopy (TEM).
Thermogravimetric analysis (TGA) was used to study the thermal stability of both bulk and
encapsulated EOs that showed an enhancement in the thermal stability of both encapsulated
EOs by about 2.18 and 1.75 folds for PO and GTO, respectively. Through UV-vis
spectroscopy, both encapsulation efficiency (EE%), loading capacity (LC%) and in-vitro
release were estimated. EE% of CS/PO NPs and CS/GTO NPs were about 82-78% and 2281%, respectively, when the initial EO amount was 0.25–1 w/w CS. Whereas, the loading
capacity (LC%) of CS/PO NPs and CS/GTO NPs were about 8-22% and 2.2-23%,
respectively for the initial EO amount was 0.25–1 w/w CS. The in-vitro release studies of both
EOs showed an initial rapid release profile followed by a slow release at two different pH
conditions: acidic pH (acetate buffer) and neutral pH (phosphate buffer saline). Furthermore,
the stability of the total phenolic contents (TPC) of both EOs in CS NPs was studied using
Folin–Ciocalteu reagent. The antioxidant activity of both pure and encapsulated PO and GTO
was evaluated by 2,2-diphenyl-1-picrylhydrazyl radical (DPPH). The antioxidant activities of
CS/PO NPs and CS/GTO NPs were improved by about 2 and 2.4 folds, respectively. Finally,
agar dilution and colony counting method were used to study the antibacterial activity of pure
and encapsulated PO and GTO against Gram positive (Staphylococcus aureus) and Gram
vii

negative (Escherichia coli) bacteria. In case of Gram positive bacteria, encapsulated PO
showed an enhanced antibacterial activity by about 39.63%, while encapsulated GTO showed
an improvement in antibacterial activity by about 57.5% on the other hand, against Gram
negative bacteria, encapsulated PO showed an enhanced antibacterial activity by about 3%,
while encapsulated GTO showed an improvement in antibacterial activity by about 1.8%.
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Chapter 1: General Introduction & Literature review

1.1.Bacterial Infectious diseases in the twentieth century
Bacterial infectious diseases such as tuberculosis, pneumonia and diarrhea were the main reasons
of mortality worldwide at the beginning of the twentieth century as represented in Figure (1).
Bacterial infections represent about 30 percent of mortality percentage that led to reduction in
life expectancy to 47 years with high mortality in infant and childhood . Pneumonia and diarrhea
were enough to kill 10% of children between the age of 1 to 4 years old1.

Figure 1:Main causes of deaths at the beginning of the twentieth century1.
By the mid of the twentieth century, the rate of mortality due to bacterial infectious diseases
declined after the introduction of antimicrobial agents2. About 50% reduction in childhood fever
mortalities caused by Streptococcus pyogenes due to the introduction of sulfa antibiotics as
Sulphadiazine. Between 1938 and 1952, the annual rate of deaths from bacterial infectious
diseases, especially tuberculosis and pneumonia, was reduced by 8.2% with the beginning of the
antibiotic era3. Despite of the success of antimicrobial agents to minimize the bacterial diseases
2

mortalities, the World Health Organization (WHO) estimated, in 1998, that bacterial infectious
diseases such as pneumonia, diarrhea and tuberculosis cause about 25% of mortalities worldwide
especially in children that represented in Figure (2). The reason behind that was due to the
development of antimicrobial resistance that becomes a serious worldwide danger4. For instance,
bacterial diseases mortalities in USA were increased at a rate of 4.8% between 1981 to 1995 due
to drug-resistant infection. One of the main reasons behind developing antimicrobial resistance is
owing to bacterial biofilm formation that provides a protection for bacterial community against
antibacterial drugs4.

Figure 2: Leading infectious disease Killer, 19985
Bacteria live in communities that are composed of different species interacting with each other
and with the environment too. They grow in association with surfaces with a higher capabilities
to adhere, persist and colonize, forming bacterial biofilm as shown in Figures (3)6. Bacterial
3

biofilm formation is based on three main stages; (i) first is the irreversible attachment of bacteria
through their secretion of adhesion for binding protein. Then, (ii) bacteria are able to proliferate
and colonize inside an envelope made of peptidoglycan and finally, (iii) the development of
biofilm maturation. Matured biofilm provides not only a protection of bacteria from
antimicrobial agents and immune system, but also a bacterial reservoir that ready to rupture for
further bacterial dispersion to infect new surfaces7. About 80% of microbial infections is owing
to bacterial biofilm resulting in higher potential of morbidity and mortality in addition to increase
in medical expenses8,9.

Figure 3: Bacterial Biofilm formation8.
1.2.Traditional solutions for combating bacterial infections
The most commonly used solution that revolutionized the treatment of bacterial infections
worldwide was the use of antibiotic and antibacterial agents for more than 50 years for both
human and animal health especially during antibiotic golden age10. They have several targets on
4

the bacteria including; cell wall and cell membranes, ribosomes, nucleic acids, cellular
metabolism and enzymes as shown in Figure (4). The selective toxicity of antibiotics depends on
the structural and metabolic differences between bacteria and mammalian cells11. Combating
biofilm infections requires using antimicrobial agent with a higher penetration power to ensure
delivery of a sufficient concentration of antimicrobial agent to kill bacteria. For instance, well
known antimicrobial agents with efficient penetration power such as rifamycins, sulfonamides,
quinolones, macrolides, lincosamides, tetracyclines, fusidic acid and oxazolidinones, are
commonly used to combat bacterial biofilm than other antimicrobials with higher molecular
weight and poor penetration power such as aminoglycosides, polymyxin and beta-lactam
antibiotics (penicillins, cephalosporins and carbapenems)12. However, many parameters should
be considered to fight microbial biofilm such as, tissue pH, therapy protocol and duration of
treatment.

Figure 4: Classes of antibiotics/antibacterial agents and their modes of action on bacteria13.
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It is well known that tissue pH can control the efficiency of antibiotics towards biofilms.
Inflammation the comes from bacterial infection results in a reduction in tissue oxygen level due
to faster metabolism rate which in turns leads to activation of cellular glycolysis process that
minimize the tissue pH (tissue acidosis). For instance, lower pH value to less than 5.2 can result
in reduction in efficiency of -lactam antibiotics while increasing efficiency rifamycin14. On the
other hand, protocol therapy to eradicate bacterial biofilm could also affect the biofilm
combating efficacy. For example, tobramycin-colistin combination therapy is significantly
efficient than monotherapy against P. aeruginosa biofilm infection15.
1.3.Mechanisms of antibiotic resistance
Antibiotic resistance in bacterial infection has negative effects upon medicine and society. Drug
resistance leads to usage of higher doses of antibiotics with a higher potential of toxicity as well
as longer hospital stays and higher mortality rate. For example, Methicillin-resistant
Staphylococcus aureus (MRSA) is associated with higher deaths percentage that added $20
billion to the total health care costs in addition to $35 billion in costs to the American society16.
Antibacterial drug resistance is based on two main mechanisms: (i) preventing the antibiotic
from reaching their targets in bacterial cell and, (ii) modifying the bacterial targets that the
antibiotic work on as represented in Figure (5)17.
Bacteria can prevent the antibiotic from reaching its targets by different mechanisms. Pumping
the antibiotic molecule out of bacterial cell through bacterial efflux pump is one of antibiotic
resistance mechanism that lowers the antibiotic concentration inside the bacterial cell.
Furethermore, bacteria can reduce the permeability of the membrane that surrounds the bacterial
cell as it makes it more difficult to pass through. On the other hand, bacterial enzymes can
inactivate the antibiotics. For instance, β-lactamase enzyme can inactivate the component β6

lactam antibiotic such as penicillins. Finally, Bacteria can modify the chamical structure of the
antibiotic that prevent the binding interaction between antibiotic and bacterial cell17.
Bacterial target modification is the second strategy for antibacterial drug resistance that depends
on different mechanisms. Mutations in the bacterial DNA can iduce a change in the structure of
the target in the bacteria inhibiting the interaction of antibiotic with the bacterial cell target.
Furthermore, bacteria can express other proteins that replace the inhibited ones by the antibiotic.
For instance, S. aureus bacteria can express a new penicillin-binding protein that resists the βlactam antibiotics antibacterial action which is the basis in apperance of MRSA strains17.

Figure 5:Resistance strategies in bacteria18.
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1.4. Reactive oxygen species and oxidative stress
Reactive Oxygen Species (ROS) are reactive molecules that come from molecular oxygen as
shown in Figure (6). Mitochondrial aerobic respiration is one of the ROS source formation as
well as oxidoreductase enzymes. ROS can induce cellular apoptosis which in turn activates the
cellular signaling cascades as they serve as both intra- and intercellular messengers. Furthermore,
ROS can damage DNA, protein, lipids and carbohydrates and is related to pathogenesis of
different diseases19.

Figure 6:Reactive oxygen species19.
Survival of the cell is based on detoxification of ROS. There is normal balance between
production and removal of ROS as represented in Figure (7)20. Elevation of ROS levels results in
a condition that is called “oxidative stress”.

8

Figure 7:Imbalance between antioxidant and free radicals levels20.

As represented in Figure (8), oxidative stress has a key role in age-related diseases such as renal
nephritis, atherosclerosis, retinal degenerations, cancer, arthritis, obesity, type 2 diabetes and
Alzheimer’s disease (AD)21.

9

Figure 8:Oxidative stress complications21.
Antioxidant enzymes such as superoxide dismutase (SOD) helps in conversion of superoxide
into hydrogen peroxide (H2O2) (equation 1)20 that is converted into water molecule through the
help of peroxisomes of eukaryotic cells (equation 2)20. On the other hand, Glutathione
peroxidase is a group of enzymes support conversion of hydrogen peroxide into alcohols20.
2 O2- + 2H+  H2O2 + O2

(1)

2 H2O2  2 H2O + O2

(2)

The challenges that face the conventional antibiotics in fighting bacterial infections and the
search for antioxidants that prevent the diseases related oxidative stresses have made many
scientists investigating a natural alternative that provides antibacterial and antioxidant activities
with minimal side effects. Aromatic plants and their EOs have been widely applied for a variety
of purposes for thousands of years. Therefore, essential oils (EOs) were one of the natural
compounds that have been investigated for their biomedical activites.
10

1.5. Essential oil
According to the International Organization for Standardization (ISO), EOs are defined as:
“colorless, highly volatile hydrophobic liquids containing complex mixtures of organic
compounds”. EOs are secondary plant metabolites that are stored in plant secretory cells and
cavities after synthesis in flowers, stems, seeds and leaves that are summarized in Table (1).
They are characterized by their lower density (less than water), lower mass (less than 300
molecular weight) in addition to their higher dissolution is organic solvents such as ethanol,
hexane and chloroform22.
Table 1:Parts of plant material containing essential oils23.
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1.5.A. Essential oil extraction
EOs are extracted from vegetables by steam distillation as well as by supercritical fluid carbon
dioxide24. Steam distillation is the most common technique used for EOs extraction. Basically, as
shown in Figure (9), the required part of a plant is subjected to minimum amount of heated
steam with enough temperature (without soaking the plant in boiling water) that cause plant cell
rupture and EOs are released with steam and condensed through a cooling condenser and finally
the EOs are separated by an oil separator. The extraction yield (93%) and the antioxidant activity
of EOs extracted by steam distillation were found to be higher than EOs extracted by hydro
distillation (soaking of plant cells in boiling water) which makes steam distillation the most
favourable technique to be used for EOs extraction

25,26

. Examples of some EOs that were

extracted by steam distillation are listed below in Table (2).

Figure 9:Steam distillation for EOs extraction23.
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Table 2:Examples of EOs extracted by steam distillation and SFE.

However, due to prolonged extraction time as well as degradation of unsaturated fatty
compounds that are present in EOs, supercritical fluid extraction (SFE) using carbon dioxide
(CO2) have been considered as an alternative medium for EOs extraction27,28. The most common
super critical fluid (SCF) in extraction is CO2 due to its lower critical temperature (Tc) (which is
the temperature needed to convert a material state into SCF state) that preserve thermal stability
of EOs during extraction. Furthermore, SCF CO2 can be evaporated easily by subjecting it to
atmospheric pressure which gives an advantage of removing any CO2 residue in EOs27,29,30.
However, pure CO2 has low extraction rate (80% extraction after 90 min) therefore, methylene
chloride is used as a modifier that enhances the extraction efficacy29. According to Figure (10),
liquid CO2 is compressed through a compressor and heated up to achieve a critical pressure (Pc)
as well as a critical temperature (Tc) that are required to achieve SCF state as shown in Figure
13

(10). Then, SCF CO2 starts to extract the EOs from plant cells that are placed in an extractor due
to higher penetration, diffusion and solubilizing powers of SCF. The EOs are dissolved in SCF
then pass through a separator that is adjusted with atmospheric pressure to evaporate CO2 and
separate EOs31. Escaped CO2 is then condensed to liquified CO2 for the next run. Examples of
some EOs that were extracted by SFE are listed in Table (2).

Figure 10:Supercritical fluid extraction (SFE) for EOs extraction31.
1.5.B. Essential oil chemical composition.
The chemical compositions of EOs are classified into two main categories; (i) oxygenated
compounds and (ii) hydrocarbons. The former are organic compounds that contain oxygen atoms
in their structures such as aldehydes, lactones, ethers, alcohols, esters, ketones and phenols while
the later contains hydrogen and carbon atoms such as terpenes and sesquiterpenes32. In addition,
phytochemicals can also be classified into; monoterpenoids, sesquiterpenoids, phenylpropanoids,
short-chain aliphatic hydrocarbon derivatives, glucosinolates and isothiocyanate derivatives as
shown in Figure (11)33.
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Figure 11:EOs representative chemical structures32.
The variation in the chemical composition of EOs is related to the difference in molecules’ types,
quantity and stereochemical structures. Furthermore, other factors can affect the chemical
compositions of EOs such as extraction methods, environmental conditions and plant organ32.
Accordingly, European Pharmacopoeia (EP) and WHO Analytical monographs have been issued
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to confirm the quality and quantity of EOs utilizing advanced analytical techniques such as Gas
chromatography (GC) and Mass spectrometry (MS)33. Generally, about 20-100 single
components are present in EOs in different concentrations. Nearly 2-3 components are
considered as main constituents with relative high proportions (20–70%) that determine the
biological activities of EOs while others are considered as trace constituents. For instance, in
Origanum species EOs, both carvacrol (30%) and thymol (27%) are the main constituents33.

1.5.C. Essential oils as natural antimicrobial and antioxidant agents
Aromatic plants and their EOs have been applied for many purposes for thousands of years. They
were used by Ancient Egyptians in embalming to inhibit the growth of bacteria. Their lipophilic
liquids, that are composed of a mixture of chemical components with a higher antibacterial
property, therefore they were used as preservative for fooda, as well as in pharmaceutical 34.
Different EOs with their antibacterial activities are listed below in Table (3).
Table 3: list of EOs against bacterial species.
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1.5.D. Essential oil antibacterial mode of action
EOs have complex chemical nature as they are composed of several components as mentioned
earlier, therefore they have different antimicrobial mechanisms as shown in Figure (12). Phenolic
components of EOs play a role in enhancing the penetration and disruption of bacterial
membranes that cause inhibition effect on cell functional properties and eventually causing
leakage of the internal contents of the bacterial cell. The reason behind that is owing to the
presence of phenolic components that are found in thymol, carvacrol, eugenol, peppermint (PO)
and green tea (GTO) can enrich the mount of saturated fatty acids (C16-C18) while decreasing the
amount of unsaturated fatty acids (C18) in bacterial cell membrane35. Furthermore, EOs
lipophilicity can detach the lipids of bacterial cell membrane making bacterial cell more
permeable. On the other hand, oregano EO can interfere with cellular energy (ATP) generation
system that reduce significantly S. aureus intracellular ATP levels. Moreover, EOs such as pcymene can disrupt the proton motive force of bacterial cell membrane that required for flagellar
movement which result in cell death36.

Figure 12:Mechanism of action and target sites of the essential oils on microbial cells37.
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1.5.E. Essential oil antioxidant mode of action
EOs exhibit their antioxidant role due to their behaviour as physical barrier to stop ROS
generation. Furthermore, they may act as chemical trap for electrons such as carotenoids, and
anthocyanidins. They may also act as chain-breaker to destroy ROS such as tocopherols and
flavonoids components32.
Generally, antioxidant agent is classified into: (i) primary and (ii) secondary antioxidants. The
former one act as a hydrogen ion doner to a radical to convert it into a new stable radical.
Secondary antioxidants can reduce the oxygen level (scavenging of oxygen or chelating metal) to
prevent initiation of ROS generation38.
1.5.F. EOs limits and challenges
All EOs antibacterial mechanisms can induce growth inhibition of some gram-positive such as,
S. aureus, Listeria monocytogenes and Bacillus cereus, less than gram-negative bacteria such as
E. coli and Salmonella Enteritidis due to the direct interaction between EOs components and
bacterial cell membrane. Hydrophilic nature of gram-positive bacterial cell wall explains the
high resistance toward plant EOs39.
Some EOs components have some degree of toxicity as shown in case of eugenol at a
concentration of 0.1 Mm that can cause rat hepatocytes membrane lysis due to the reduction of
the surface tension of the membrane. Furthermore, carvacrol can inhibit the proliferation of
purified porcine lymphocytes39.
Beside EOs’ higher volatility, the direct exposure of EOs to heat, light, moisture and oxygen can
trigger chemical and/or enzymatic reactions such as dehydrogenation, oxidation, cyclization and
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isomerization reactions that in turn lead to the decomposition of their chemical constituents and
changing in their viscosity and organoleptic properties40. For instance, oxygenated terpenoids
such as menthol and menthone that are present in PO were converted into ketones, acids, and
aldehydes upon exposure to atmospheric conditions, and consequently, these new products result
in skin hypersensitivity reaction and allergic dermatitis41. On the other hand, polyphenols such as
epigallocatechin gallate that were found in GTO are exposed to epimerization and oxidation
reactions leading to its degradation into catechin monomers and gallic acid42.
The above drawbacks of using EOs in bulk form in different biomedical application have made
many scientists looking for a magical solutions to overcome these limitations and improve EOs
properties. Nanotechnology opended new avenues towards preparing novel materials at much
smaller scale – nanoscale - than their bulk counterparts, and exhibit promising improvement in
material properties.
1.6. Nanotechnology
Nanoscience is a multidisciplinary science that connect chemistry, physics, engineering,
pharmacy medicine and other sciences together. Therefore, nanoscience is considered a real
convergence among distant knowledge areas. Nanoscience impact is very strong on many fields
connected to life and health. Nanotechnology (applied nanoscience) may provide new track for
combating both microbial disease as well as oxidation stresses. Nanoscience is the study
behavior of materials that has one dimension between 1 to 100 nm as represented in Figure
(13)43.
Nanomaterials are classified into four classes; (i) zero dimensional nanomaterials (all three
dimensions are less than 100 nm) such as nanoparticles and quantum dots. (ii) one dimensional
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nanomaterials have two dimensions less than 100 nm such as nanotubes (iii) two dimensional
nanomaterials (with one dimension less than 100 nm) such as thin films. And (iv) finally, three
dimensional nanomaterials which are composed of assembled nanomaterials such as
nanocrystalline grains. Dealing with material in the nanoscale offers higher innovation potential
in many fields, particulary in the fields of antibacterial and antioxidant agents43.

Figure 13:Types of nanomaterials44.
1.7. Nanoparticles mechanisms for combating microbial resistance
1.7.A. Nitric oxide-releasing nanoparticles (NO NPs)
Nitric oxide-releasing nanoparticles (NO NPs) have a strong antibacterial activity due to the
formation of reactive nitrogen oxide species (RNOS) as a result of NO-superoxide interaction
inside bacterial cell especially when NO level exceeds 1nM as represented in Figure (14).
Furthermore, NO has the ability to bind with bacterial membrane protein as well as its efficiency
to break DNA strands. Moreover, NO enhances the generation of hydrogen peroxide that causes
a damage of DNA as well as their ability to simulate human innate immunity response. For
instance, NO NPs shows a good antibacterial activity against spores of Bacillus cereus45.
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Figure 14:Nanoparticles multiple antibacterial mechanisms16.
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1.7.B. Chitosan nanoparticles
Chitosan nanoparticles (CS NPs) can combat microbes with different mechanisms. CS is derived
from chitin (polymer of N-acetyl-glucosamine residues) after deacetylation at random monomer
residues as shown in Figure (15) with a pKa of 6.5. At a pH below 6.5 (as in bacterial biofilm),
all CS amino groups become protonated and bind with bacterial cell walls and plasma
membranes (which are negatively charged) that increases the permeability of the microbial cell
wall. As represented in Figure (14), CS NPs are also able to bind to bacterial DNA and
inhibiting both transcription and translation processes46. Furthermore, CS NPs can reduce the
activity of metalloprotein through their chelation power with bacterial cytoplasmic metals.
Encapsulation of CS into nanoparticles increase the surface area per volume that results in
intense positive charges on CS NPs surface as well as enhancing their solubility in physiological
environment. It was previously reported that CS NPs have strong antibacterial activity against S.
aureus and E. coli than CS polymer. It was found that the molecular weight of CS could affect
the antibacterial activity of CS NPs, so, NPs containing CS with lower molecular weight have
higher bactericidal activity against gram negative bacteria while those containing higher
molecular weight showed higher bactericidal activity towards gram positive bacteria47.
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Figure 15:Chitin and chitosan chemical structures47.
1.7.C. Silver nanoparticles
As represented in Figure (14), silver nanoparticles (Ag NPs) can reduce biofilm resistance
through different mechanisms. Like CS, when silver is dissolved in water, it carries positive
charge that interacts with cell wall protein containing sulfur and phosphorus groups and thus
creating holes in bacterial cell membrane that allows the flow of cellular contents out of the cell
and causes death of bacteria48. Efficiency of Ag NPs against gram negative bacteria was found to
be higher than gram positive bacteria because of thinner gram negative bacterial cell wall.
However, it has also been argued that silver penetration power through gram negative bacterial
membrane is low due to interaction between the positive charge of silver and the negative charge
of lipopolysaccharide of the outer bacterial membrane49.
1.7.D. Copper nanoparticles.
The anitibacterial activity of Copper nanoparticles such as copper oxide nanoparticles (CuO
NPs) and copper nanoparticle-loaded polymer rely on two mechanisms. First, copper ion has an
ability to bind with the carboxyl and amine groups that are located on the microbial cell surface
such as B. subtilis. ROS formation is the second mechanism50. Higher concentration of copper
ion induces the formation of ROS that inhibits DNA replication as well as protein synthesis as
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represented in Figure (14).

It has been reported that copper nanoparticles have strong

antibacterial effect against E. coli, S. aureus, and Listeria monocytogenes that showed a dose
dependent activity50.
1.7.E. Magnesium nanoparticles.
Magnesium nanoparticles have bactericidal effect based on different mechanisms. Like copper
nanoparticles, they induce formation of ROS resulting in lipid peroxidation and pore formation
through bacterial cell membrane. Furthermore, they adsorb halogen molecules from bacterial
cytoplasm on their surfaces as represented in Figure (14). It has been reported that magnesium
nanoparticles could inhibit the growth and biofilm formation of E. coli and S. aureus51.

1.8. EOs loaded in nanosystems
Nanoencapsulation of EOs provides an efficient approach to enhance the stability, controlled
release, reduced EOs volatility, improved patient compliance and minimized the interaction with
external environment conditions (light, pH, oxygen and moisture). Furthermore, unique smaller
size could enhance cellular penetration and uptake. Different polymeric and lipid based
nanocarriers are structured with a characteristic biodegradability and biocompatibility as shown
in Figure (16)24.
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Figure 16:Nanosystem platforms for EOs24.
1.8.A. Polymer-Based Nanocarriers.
Polymeric nanocarriers are divided into nanocapsules and nanoparticles (nanospheres).
Nanocapsules are composed of outer polymeric membrane encapsulating material in inner core
or to be adsorbed on the outer surface while nanoparticles (nanosphere) composed of matrix
system. EOs might be incorporated within the polymeric membrane or encapsulated in the core
that are illustrated in Figure (17)52. Different EOs were loaded into polymeric nanocarriers as
listed below in Table (4) with their average size, zeta potential loading capacity and biological
activities. In case of encapsulation of EOs in chitosan nanoparticles, two-steps method
(emulsification followed by ionic gelation) are used. Table (5) lists previous published studies
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specificlly for essential oils that encapsulated in chitosan with the surfactants used, organic
solvent as well as their targeted biomedical application.

Figure 17:Schematic Representation of nanoparticle and nanocapsules with adsorbed or
encapsulated EOs52.

Table 4:List of EOs loaded into polymeric nanocarriers.
EO

Polymer

Preparation
method
Emulsification
and ionic gelation

Size
(nm)
< 100

Eugenol

Chitosan

Oregano

Chitosan

Emulsification
and ionic gelation

40–80

Lippia
sidoides

Alginate/
cashew

spray-drying

223–
399
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LC and Formula/benefits References
EE%
LC=
- nanoparticles
[53]
12%
- thermally stable
- higher antioxidant
activity
LC =
- nanoparticles
[54]
3 – 8%
- thermally sTable
- higher antioxidant
activity
- higher
antimicrobial
activity
LC=
- nanoparticles
[55]
1.9 -4.4 - fungicide

gum
Jasmine

complex
coacervation

600

----------

Thymol

gelatin/
arabic
gum
Zein

liquid–liquid
dispersion method

200

EE= 80

Eugenol

PLGA

173
225

- EE = 98

Carvacrol

PLGA

Thymol

Methyl
cellulose
ethyl
cellulose

Emulsion
evaporation
method
solvent
displacement
process
displacing
the
ethanol
solvent
with water

LC = loading capacity

209.8

LC = 21

420

EE=
43.53%

EE = encapsulation efficiency

- bactericide
activities
- nanocapsules
- heat-resistant
ﬂavour
- nanoparticles
- suppress Gram+ve bacterium
- nanoparticles
- inhibiting growth
of Salmonella
- nanocapsules
- antimicrobial
activity
- nanocapsules
- reduce E. coli

[56]

[57]

[58]

[59]

[60]

PLGA = polylactic glycolic acid

Table 5:List of EOs loaded into CS NPs, and their biomedical application using two steps
encapsulation method.
Essential oil

Surfactant

Organic solvent

Application

Reference

Carum copticum

Tween 80

Dichloromethane

Antioxidant

[61]

Carvacrol

Tween 60

Ethanol

Model system

[62]

Eugenol

Tween 60

Ethanol

Antioxidant

[53]

Oregano

Tween 80

Dichloromethane

Antifungal

[54]

Satureja hortensis

Tween 80

Ethanol

Antioxidant

[63]

Zataria multiflora

without surfactant

Ethanol

Antifungal

[64]
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1.8.B. Lipid-Based Nanocarriers.
Lipid-based nanocarriers are classified into: nanoemulsion, liposomes, solid lipid nanoparticles
(SLN), and nanostructured lipid carriers (NLC). Liposomes are bilayer vesicle composed of
association of phospholipids (amphiphilic nature) that can carry both hydrophobic (EOs) and
hydrophilic drugs. SLN and NLC are solid particles with lipid core for encapsulation of EOs.
They have a capacity of dissolution in aqueous media and maintain or enhance EOs biological
activity.
1.8.B.1 Nanoemulsions
Nanoemulsions are sTable homogenous system that composed of two immiscible liquids with a
droplet size less than 500nm as shown in Figure (18). They are prepared with lower surfactant
concentration, in contrast to microemulsion (droplet size more than 500 nm), therefore, irritation
that comes from surfactant is not likely to happen. Nanoemulsions have a higher kinetic stability
owing to their smaller size and stearic effect. The antimicrobial feature of EOs nanoemulsion is
due their higher surface tension that enhance penetration power of EOs through bacterial cell
membranes. Different EOs were loaded into nanoemulsion that are listed below in Table (6)
with their average size, composition and biological activities24.

Figure 18:Illustrative diagram of nanoemulsion24.

28

1.8.B.2. Solid Lipid Nanoparticles.
Solid lipid nanoparticles (SLN) are nanoparticles with a diameter ranging from 50 nm to 1 um
and composed of different lipids such as triglycerides and waxes. EOs are immobilized in the
core or in the outside part of SLN which provide a protection from external environment and
provide a sustained release for EOs as shown in Figure (19)24. Different EOs were loaded into
SLN that are listed below in Table (6), with their average size, composition and biological
activities.

Figure 19:Illustrative diagram of SLN65.
1.8.B.3. Liposomes
Liposomes are type of colloidal delivery systems for both hydrophilic and lipophilic (EOs)
drugs. They consist of phospholipids that are assembled in one or more layered vesicular form.
They may be unilamellar vesicles (ULV) of one bilayer with diameter ranging from 25 nm
(small ULV) to more than 100 nm (large ULV). Multilamellar vesicular vesicles (MLV) are
other type of liposomes that composed of multilayers with a diameter exceeding 1 um that are
represented in Figure (20). They provide a protection against environmental degradation of EOs
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and enhance the aqueous solubility as well24. Different EOs were loaded into liposomes that are
listed in Table (6), with their average size, composition and biological activities.

Figure 20:Illustrative diagram of liposome65.
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Table 6:List of EOs loaded into lipid-based nanocarriers
EO
Melaleuca
alternifolia

Nano
Carriers
Nanoemulsion

Zedoary
turmeric

Nanoemulsion

Artemisia
arborescens

SLN

Nigella
sativa

SLN

Zataria
multiﬂora

SLN

SDS, PEG and 650
cetyl alcohol

Santolina
insularis

Liposome

-----

Artemisia
arborescens

Liposome
(MLV)

Atractylode
macrocepha

Liposome

hydrogenated
soya PC and
cholesterol
hydrogenated
(P90H) and soy
PC
PC and
cholesterol

Origanum
dictamnus

Liposome
(MLV)

PC and
cholesterol

-------

PEG = polyethylene glycol

Composition

Size
(nm)
lecithin, Tween 7420 and glycerol 365
monooleate
ethyl
oleate, 68.3
Tween 80
Transcutol P
compritol 888 223
ATO
and
Poloxamer 188
Palm oil Sofisan ----154,
sorbitol,
and water

252408
173

LC &
EE%
-------------

Properties
and activities
enhance
antimicrobial
activity
LC = enhancement
30%
of both AUC
and Cmax of
turmeric oil
EE = antiviral
87%
activity
(HSV-1)
-------- -antimicrobial
-activities
-antioxidant
activities
EE=
-antimicrobial
38.66 activities
%
-------- -antiviral
activity
(HSV-1)
EE = -antiviral
60activity
74%
(HSV-1)
LC = - enhanced EE
5.18% -increase
EE = dissolutin rate
82.18
%
LC = Antioxidant
4.16% activites and
antimicrobial
activites

SDS = sodium dodecyl sulfate
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Thesis Scope and Objectives
The scope of the study as shown in Scheme (1) was to encapsulate natural EOs such as “GTO”
and “PO” in natural biodegradable polymeric nanocarrier as CS. The aim of the encapsulation is
to enhance the thermal stability of the EOs, protect their phenolic contents, reach sustained
release profile, improve their antioxidant activity and to improve their antibacterial activities.
The novelty in this work relies on converting these EOs specifically into nanoform that are not
found in previous published literature. The selection of PO and GTO was mainly based on the
clear difference and variation in their chemical composition, phenolic contents, phytochemical
components and their well-established biomedical activities.
The preparation of encapsulated EOs NPs was followed by examination of these NPs via
different characterization techniques. Furthermore, Different studies were used to estimate the
EE%, LC% of the EOs, thermal stability, in-vitro release at different pH media, and finally the
ability of CS NPs to preserve the phenolic contents. After optimization of the NP formulas, they
had been investigated on their antioxidant activity and antibacterial activities against both Grampositive and Gram-negative bacteria.
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Scheme 1: Study scope diagram.
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Chapter 2: Materials & Methods
2.1. Materials:
Sodium tripolyphosphate (TPP), Tween 80, (2,2-DiPhenyl-1-Picryl Hydrazyl) (DPPH) and
Dichloromethane were purchased from Sigma Aldrich Co. (USA). Chitosan of medium
molecular weight (84,8 % degree of dealkylation) was purchased from (Primex ehf, Chitoclear,
Iceland). Green tea as well as peppermint essential oils were obtained from Nefertari Natural
Body Care Line (Cairo, Egypt). Folin–Ciocalteu reagents and Gallic acid were supplied by
Merck Chemicals Co. (Germany). Glacial acetic acid and sodium carbonate were obtained from
Adwek Co. (Egypt). All materials were consumed as received without further treatment.
2.2. Compositional analysis of PO and GTO
The Gas Chromatography (GC) coupled to Tandem Mass Spectrometry (GC/MS/MS) technique
was used to assure the identity and to identify the components of both PO and GTO75. The
analysis was carried out using a GC (Agilent Technologies 7890A) with capillary column (30 m
× 0.25 mm i. d. and 0.25 μm film thickness to separate the component of EOs that were carried
by helium gas (linear velocity of 1mL/min) to mass-selective detector (MSD, Agilent 7000))
where they are identified. The identification of components relying on the comparison of the
chemical components mass spectra and retention time with standard compounds and by
computer matching with NIST (National Institute of Standards and Technology) library75.
2.3. Preparation of EOs loaded CS NPs
[

Preparation of EOs loaded CS NPs was performed at two steps based on the method described by
(Hosseini et al., 2013)54 and (Woranuch et at.,2013)53 with slight modifications. The process of
EO encapsulation in CS NPs relied on two steps (as shown in Figure (21)); Step 1: a process
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involves oil in water (O/W) emulsification in which an aqueous phase, composed of CS and
Tween 80 dissolved in acidic solution, was emulsified with an organic phase containing EO
through rotor stator homogenizer with adjustable speed (rpm) and duration (min). As a result,
O/W nanoemulsion was formed. Step 2 is a process known as ionic gelation that is commonly
used in order to formulate composite nanoparticles, and involves a negatively-charged crosslinker such as sodium tripolyphosphate (TPP) was added to the nanoemulsion obtained in step 1
to interconnect the positively charged CS polymer chains as represented in Figure (22A) 56,61,76.

Figure 21:Schematic illustrations of EO encapsulation two-step process.
There were mainly two factors that thoroughly examined and were found to greatly affect the
size of the formulated NPs, their polydispersity index (PDI) and zeta potential (ZP) during the
preparation of CS/PO NPs and CS/GTO NPs; (i) the homogenization parameters (speed and
time) and (ii) the concentrations of the components (such as TPP, and CS/EO ratio) as
represented in Figure (22B). The CS concentration and tween 80/CS ratio were kept constant
during all experiments.
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(A)

(B)

Figure 22: (A) chemical structure of chitosan ionically crosslinked with TPP76, (B) Parameters
that affect the size, PDI and ZP of formulated NPs.
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2.3.A. Oil in water (O/W) emulsion preparation
In the preparation of O/W emulsion, the aqueous phase was prepared by dissolution of CS
powder in 1% (v/v) glacial acetic acid to get a solution of 1% CS solution after overnight
shaking. To 50 mL CS solution, tween 80 (CS: Tween 80 was 1:1.12 w/w) with HLB
(hydrophilic lipophilic balance) of 15.9 was added and stirred for two hours at 45

to form an

aqueous phase of the emulsion. On the other hand, the oily phase was prepared by dissolving PO
(0.12, 0.24, 0.36 and 0.48 g) in 5mL dichloromethane to get concentrations of (CS: PO) of
1:0.25, 1:0.5, 1:0.75 and 1:1.00 w/w). Then, the oily phase was added drop-wise into the aqueous
phase during homogenization at 14000 rpm for 10 min under an ice bath condition to get an O/W
emulsion. GTO was treated as PO. It should be pointed out that the homogenization speed and
duration are chosen based on the preliminary studies that are illustrated in chapter 3 of the result
and discussion.
2.3.B. Ionic gelation process and separation of the prepared NPs
In order to finally form the NPs, 50 mL of 0.4% (w/v) aqueous TPP solution was gradually
added to 50 mL emulsion under 400 rpm stirring via magnetic stirrer (Phoenix, RSM-01SH,
Germany) for 40 min at a room temperature to allow the cross-linking of CS polymer and to
facilitate the formation of NPs. The formed NPs were collected by 10000 rpm centrifugation for
30 min at 4 , and followed by washing several times by deionized water. The formed wet
pellets were dispersed in distilled water to get a homogeneous suspension via probe sonicator
(Qsonica 500, Qsonica, LLC, USA), for 4 min. with a sequence of 2 seconds sonication and 1
second rest in an ice bath. Finally, trehalose dihydrate which acts as a cryoprotectant was mixed
via magnetic stirrer (Phoenix, RSM-01SH, Germany) with the nano-suspensions (NPs: Trehalose
ratio of 1:1) and subsequently freeze dried at -65
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for 72 hrs. It should be pointed out that the

TPP concentration is chosen based on the preliminary studies that are illustrated in chapter 3 of
the result and discussion. CS NPs were stored at the refrigerator until further analysis. CS: EOs
weight ratios that were used for the present study are listed in Table (8).
Table 7: List of CS NPs samples with their CS:EOs weight ratios.
sample No Weight ratios (w/w)
1

CS NP (1:0)

2

CS/GTO (1:0.25)

3

CS/GTO (1:0.50)

4

CS/ GTO (1:0.75)

5

CS/GTO (1:1.00)

6

CS/PO (1:0.25)

7

CS/PO (1:0.50)

8

CS/PO (1:0.75)

9

CS/PO (1:1.00)

2.4. Characterization of the prepared NPs
2.4.A. Particle size and zeta potential of the prepared NPs
To study the nanoparticle hydrodynamic size and zeta potential Malvern nano-series Zetasizer
(UK), with a helium-neon laser operating at 90° scattering angle with a power of mW and
wavelength of 633 nm at 25

, was used. Freshly prepared nano-suspension were diluted with

distilled water to a concentration of (1 mg/mL), according to Zetasizer manual specification,
before measurement. Triplicate samples were analyzed and mean value was reported.
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2.4.B. Morphology of the prepared NPs
To study the morphology of the prepared NPs, Hitachi H-7650 (Japan) transmission electron
microscopy (TEM) analysis was carried out using a voltage of 200 kV. Before lypholization
process, 1mL of nano-suspension in the concentration (1mg/mL) was diluted with 50 mL
deionized water and spread onto a copper grid and left to dry at a room temperature before TEM
analysis.
2.4.C. Fourier transform InfraRed (FTIR) Spectroscopy analysis
Fourier transform InfraRed (FTIR) Spectroscopy (Thermo Scientific Nicolet 8700, USA) was
used to study the chemical characteristics of the NPs. Pure EOs, CS NPs, CS/PO NPs and
CS/GTO NPs were analyzed via 16 scans at a resolution of 4 cm-1 at a range of 400–4000 cm-1.
Lyophilized NPs were triturated with potassium bromide and compressed in form of pellets.
2.4.D. Thermogravimetric analysis (TGA) analysis
To estimate the thermal stability of nanoparticles and EOs, Q50 TGA Thermogravimetric
Analyzer (TGA) was performed. Each 4-10 mg of lyophilized powder were placed in the
platinum pan and heated up by TGA furnace with heating rate of 10 °C/min under nitrogen
atmosphere and from 25 to 600 °C.
2.4.E. Powder X-ray diffraction (XRD) analysis
To study the material packing characteristics and crystallinity, X-ray diffraction (XRD) via a
(Bruker AXS D8, Germany) diffractometer was used in operation conditions of 40 mA current, a
power of 40 kV and radiation with Cu Kα (λ = 1.5 Å). Lyophilized samples were scanned over a
2θ range of 5° to 50° at a speed of 0.03° per second.
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2.5. Determination of encapsulation efficiency (EE%) and loading capacity (LC%)
EO amount that was encapsulated in CS NPs was determined by UV–Vis spectrophotometry54,62.
Each of 30 mg of GTO loaded CS NPs and 80 mg of PO loaded CS NPs were dropped into 10
mL dehydrated ethanol and centrifuged at 12000 rpm for 20 min at 25 °C as reported by (Deka et
al., 2016)77. The EO content in the supernatant was analyzed using UV–Vis spectrophotometry at
a wavelength of 274nm and 227nm for GTO and PO, respectively. The amount of GTO and PO
was calculated by suitable calibration curve of pure GTO as well as PO in ethanol with R 2 of
0.996 and 0.999, respectively. CS NPs was used as a blank, however it was treated likewise as
CS/PO NPs and CS/GTO NPs. Triplicate samples for each batch were recorded.
The loading capacity (LC) along with encapsulation efficiency (EE) were estimated from
Equations (3) and (4) respectively54:

2.6. In-vitro release studies
40 mg of dried NPs (samples 5 and 9 that are in Table (8)) were placed in a dialysis bag (1200014000 KDa), containing 2 mL of release media (40% ethanol and 60% phosphate buffer saline
with a pH of 7.4) or (40% ethanol and 60% acetate buffer with a pH of 3), and incubated in 13
mL of the same release media at room temperature under gentle shaking. The reason behind
choosing acetate buffer and phosphate buffer saline, is to mimic the stomach and blood pH in the
human body and to understand the release behavior if these formulas were taken via oral or
parenteral routs. Specific volume of release media at specific sampling time intervals was taken
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for analysis, with addition of an equal volume of fresh release media. Total cumulative amount
of GTO and PO (g) in volume of the release medium (mL) that were encapsulated in NPs, was
estimated through UV–vis spectrophotometer at 274 nm and 227 nm for GTO and PO
respectively54,56,61,63. The percentage of cumulative EO released represented by the ratio of the
cumulative amount of EO released at each time interval (Mt) to the initial amount of the EO
encapsulated in the NPs (M0) are illustrated in equation (5)54.

2.7. Estimation of Total phenolic contents (TPC)
Folin–Ciocalteu method was used to estimate the contents of total phenolic contents of pure EOs
as well as in their encapsulations61. Pre-determined amount of CS NPs, PO, GTO, CS/PO NPs
and CS/GTO NPs were mixed with dehydrated ethanol to get a final concentration (3% w/v) and
(8% w/v) for GTO and PO, respectively. On 0.5 mL of each sample, 2.5 mL of (10% v/v)
aqueous Folin–Ciocalteu reagent and left for 4 min. Then, 2 mL aqueous solution of 7.5% (w/v)
sodium carbonate was dropped to the mixture and left in the dark for 6 hrs at room temperature.
Finally, all the samples were centrifuged for 3 min at a speed of 10000 rpm and the supernatant
was sucked out for measuring the absorbance at 765 nm using a spectrophotometer. To estimate
the TPC, different concentrations of gallic acid (0.01 – 0.1 mg. mL-1) in ethanol were treated like
the samples, and a standard calibration curve was built (R2= 0.99) and EOs TPC was expressed
in mg gallic acid that is equivalent to 1 gram of each EO as represented in equation (6)61.
mg GAE/ g oil =

(6)
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where, (A) is the amount of gallic acid that gives the same absorbance as the sample (calculated
from the calibration curve), and (B) the amount of sample that was used.
2.8. Investigation of the antioxidant activities of NPs
The antioxidant activity of EOs loaded CS NPs was examined using DPPH free radical
scavenging assay as illustrated by (Chen et al., 2009)78 with slight modification. First,
predetermined amounts of pure PO, pure GTO, CS/PO NPs and CS/GTO NPs (samples 5 and 9
that are in Table (8)) were dispersed in 2 mL of (ethanolic DPPH solution (0.05 mM) and left for
2 hours in the dark at ambient temperature. The samples containing encapsulated EO were
centrifuged for 3 min to take the supernatant for analysis. Spectrophotometer at 517 nm was used
to measure the absorbance of samples considering dehydrated ethanol as a blank. The percent
inhibition of DPPH was calculated using equation (7)61:

where Acontrol is the DPPH absorbance and Asample is the sample absorbance.
2.9. Investigation of the antibacterial activities of the NPs
Agar dilution and colony counting methods were used to investigate the impact of encapsulation
of PO and GTO on the antibacterial activity against both Staphylococcus aureus (S. aureus) and
Escherichia coli (E.coli) as examples for Gram positive and Gram negative bacteria,
respectively (Wei et al., 2009)79. E. coli and S. aureus were cultivated in Luria broth (LB)
medium (10 g peptone, 5 g yeast extract, and 10 g sodium chloride per liter) aerobically for 24
hours at 37 °C. Tubes turbidity was noted visually before and after incubation. All EOs and NPs
were previously kept under UV light for 2 hours for sterilization. After overnight growth, 2.5 mL
of the bacterial culture were taken in falcon tubes containing 5 mg of CS NPs, CS/PO NPs,
44

CS/GTO NPs, and the corresponding amounts of pure PO (1.11 mg) and pure GTO (1.15 mg) for
an overnight incubation at 37 °C on shaking platform at 250 rpm. Serial dilutions were prepared
from the falcon tubes by addition of sterile LB agar and the 7th fold dilutions were spread on
nutrient agar and cultured at 37 °C for 24 hrs then the colonies were quantified. Additionally, a
positive control was prepared (LB broth with incubated bacteria) to check the growth of
incubated bacteria, and a negative control shows the sterility of the LB agar medium, and a
negative control was prepared (only LB broth) to check for sterility of the media used in the
experiment. The antibacterial activity was estimated through the reduction in numbers of the
bacterial colonies after introducing the sample compared to the positive control. Percent
inhibition of bacterial growth was calculated using equation (8)79:

C and A are the bacterial colonies of positive control and treated plated respectively.
2.10. Theoretical background
2.10.A. Rotor-Stator homogenizer
Rotor-stator homogenizer is a type of cutting blade mixers that belongs to mechanical
homogenizers80. The homogenization action relies on the movement of a rotor at a very high
rpm that creates extremely powerful shear force occurring within the narrow gap between the
rotor and the stator. In other word, the close proximity of the inner revolving rotor and outer
fixed stator creates a circumferential force that expels material between the spaces of the rotorstator generating cavitation and extreme turbulence and converting a bulk sized material into
nano-sized material in a very short period of time as illustrated in Figure (23). The main
application of a rotor-stator generator type homogenizer is to make dispersions and emulsions in
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a nano-sized form81. To optimize the rotor stator homogenizer, many variables should be
controlled such as; design and size of the rotor-stator probe, tip speed, duration of
homogenization, vessel shape and positioning of rotor-stator as well. On the other hand, sample
condition affecting the homogenization efficiency for example are; the sample initial size,
medium viscosity, sample volume and concentration81.

Figure 23:Rotor-stator type homogenizer80.
2.10.B. Probe sonicator
Probe sonication or ultrasonicator as represented in Figure (24a), is a device exerts its action by
generating powerful ultrasonic waves in a liquid medium causing cavitation phenomenon.
According to cavitation, ultrasonic waves have a pressure that causes liquid streaming that
results in an immediate development of micro-sized bubbles which grow and merge until they
reach their critical size. Subsequently, large sized bubbles vibrate aggressively, and finally
collapse generating a shock wave with an enough power to disrupt covalent bonds in a dispersed
material triggering deagglomeration as shown in Figure (24b). To optimize the efficiency of
probe sonicator, many variables should be controlled such as tip amplitude and intensity,
temperature, material concentration, vessel capacity and shape81. Regarding of specifications of
probe sonicator, piezoelectric horn produces vibrations of 15- 25 kHz with a power vary from 10
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to 375 Watts. It should be pointed out that the probe sonicator is considered a direct sonication
technique where the probe is immersed directly into the suspension which is more powerful than
the indirect sonication technique that relies on immersing the container in the liquid that is
propagated by ultrasound waves.81.

Figure 24:A typical probe sonicator (a), The phenomena of cavitation (b)81.

2.10.C. Lypholizer (freeze dryer)
Freeze-drying or lypholization is an extensively used process for drying of colloidal carriers
including liposomes, nanoemulsions and nanoparticles in order to enhance the stability of these
carriers. A typical lypholizer is composed of a drying chamber including temperature-controlled
shelves that are connected to a condenser chamber and vacuum pumps Figure (25a). Lyophilized
product is characterized by intact characteristics of the product such as; nanoparticle size
distribution, intact activity of encapsulated drug and long-term shelf life. Lypholization cycle is
divided into three stages: (i) solidification, (ii) ice sublimation and (iii) desorption of unfrozen
water that are represented in Figure (25b).
First, in solidification phase pure water in colloidal suspension is converted into ice crystal
resulting in an increase in the suspension concentration and viscosity that inhibits further
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crystallization. Second, applying vacuum which leads to depression of the boiling point that in
turn induces ice sublimation stage. At the end of the second stage, porous pellet is formed due to
sublimation of ice crystals. Finally, desorption of unfrozen water stage is characterized by
removal of water that did not come out during the first and second stages. However,
lypholization may generate freezing and dehydration stresses as well as phase separation during
freezing that could destabilize and induce irreversible fusion of nanoparticles in colloidal
suspension. Therefore, cryoprotectant (excipient that protect nanoparticles during freezing phase
through immobilization of nanoparticles within a glassy matrix) including; trehalose, sucrose,
glucose and mannitol should be incorporated.

Figure 25:A typical benchtop freeze dryer (a), the lypholization cycle (b) 82.
2.10.D. Dynamic light scattering (DLS, Zetasizer)
Dynamic Light Scattering (DLS) is a system that shines suspended particles with a laser beam
and investigating the intensity fluctuations in the scattered light. The DLS system consists of six
components as shown in Figure (26a); (i) a laser light source for sample illumination, (ii) the
sample that is placed in plastic cuvette, (iii) two avalanche photodiode detectors (positioned at
certain angles) for detecting the scattered light that comes out from the sample, (iv) an attenuator
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to reduce intensity of scattering if it is outside detector range, (v) a collector and finally (vi)
display software.
DLS system measures particle size depending on the measurement of Brownian motion (random
collision) between nanoparticles and solvent molecules that is based on Stokes-Einstein equation
(9)83.

According to Stokes-Einstein equation, d(H) is the hydrodynamic radius, k is Boltzmann’s
constant, T is the absolute temperature,

is the medium viscosity and D is the velocity of

Brownian Motion. Therefore, through measuring Brownian motion velocity, hydrodynamic size
can be measured83. It should be noted that, the hydrodynamic size is related to a thin, electric
dipole layer of liquid medium that adheres to the surface of nanoparticle, influencing the
Brownian motion of the nanoparticle. Smaller particles size exhibits much easier random
collision with solvent molecules than larger particles. Velocity of Brownian motion is measured
by detecting the rate of scattered light fluctuation. Therefore, the smaller particle size, the more
rapid fluctuation in scatter light occurs as represented in Figure (26b). DLS could be quite
advantageous if compared to other techniques, as it is a non-invasive technique that requires
minimal sample preparation and no calibration is required for it. In addition, DLS instruments
are quite much more compact and affordable and they offer user friendly interfaces that allows
users to perform comprehensive data analysis84
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Figure 26:A typical Dynamic light scattering system (a) , DLS principle (b) 83.
2.12.E. Transmission electron microscopy (TEM)
Transmission electron microscopy (TEM) is a microscopy technique that depends on the
interaction of a sample deposited on the surface of cupper grid with a beam of electrons that is
transmitted through it. A typical TEM, it composed of; (i) high voltage (100-400 kV), (ii)
Electron source of 0.1-1µA (electron gun), (iii) condenser system of lenses and apertures that
controls the illumination on specimen, (iv) objective lens for imaging, (v) projector lens that
magnifies
image as represented in Figure (27)85. The image that results from high-energy (>100 kV)
electron interaction with the sample is magnified and focused onto a fluorescent screen. In the
TEM image, the regions where electrons do not pass through the sample results in a dark image.
Image resolution of the microscope relies on the wavelength of radiation according to Abbe's
equation (10)85:

(10)
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Where, (d) is the image resolution, (

wavelength of imaging radiation, (n) refraction index of

medium between source and lens and ( ) is the half angle of the cone of light from specimen
plane. Image resolution (d) is the shortest distance between two points that can be distinguished
by the camera system. Based on Abbe's equation 7, TEM images are characterized with a
significantly higher resolution (0.2 nm) due to small electron wavelength (de Broglie
wavelength). TEM image contrast is due to the thickness and composition of the material as well
as absorption of electrons in the material85.

Figure 27:A typical TEM components85.
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2.12.F. Fourier transform infrared spectroscopy (FTIR)
Fourier transform infrared spectroscopy (FTIR) is a spectroscopic technique that measures the
vibrational oscillation of molecular bonds in forms of molecular stretching and bending of
chemical bonds when they are subjected to a matched light wavelength (mid IR wavelength of
2.5 μm and 25 μm), that generates absorption peaks in the IR spectrum. FTIR is a rapid a
technique that estimate the chemical composition of the system (qualitative analysis) as well as
identification of characteristic functional groups in the formula. FTIR depends on Michelson
interferometer as represented in Figure (28). In Michelson interferometer, He-Ne laser beam are
splitting into two halves, the first half of the light hits a fixed mirror while the second part hits
the moving mirror. Then, the two halves are recombined with different traveling distances that
generates interference pattern due to the difference in the path lengths. The resulted
interferogram shows variable transmitted intensities versus time that are converted into a
frequency spectrum using a Fourier transform mathematical function. Light with interference
pattern passes through the sample and the detector can collect the interfering signals and
generates a plot of the response86.
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Figure 28:Schematic diagram of Michelson interferometer87.

2.12.G. X-ray diffraction analysis (XRD)
X-Ray Diffraction (XRD) analysis provides a valuable information about material packing
character as well as material crystallinity through interpretation of diffraction peaks (shape,
intensity and position). XRD relies on Bragg’s law (equation 11) that studies the conditions
needed for light diffraction. According to Bragg’s law,
spacing between the planes and

is the wavelength, while d is the

is a diffraction angle.
(11)
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According to Figure (29 a, b), when a fixed wavelength of X-ray ( ) is applied with an incident
angle ( ) on planes of atoms having a space (d), diffraction peak will simultaneously be
generated at a specific angle ( ). The angle between incident beam and the detector angle is
called diffracted angle (2 ). Therefore, according to the peak position (at a specific angle ), the
spacing between the planes (d) can be estimated. On the other hand, the types of atoms in
diffracting plane can easily be determined by peak intensity88.

Figure 29: Bragg’s hypothesis (a), Schematic diagram of a typical XRD system (b)88.
2.12.H. Thermal gravimetric analysis (TGA)
Thermal gravimetric analysis (TGA) provides useful information about the behavior of a
material during heating conditions. TGA can estimate the impact of temperature on the
material’s weight change that helps in understanding the thermal properties of a material. The
sample is heated in a controlled way in an oven with an environment of different gases. The
weight difference is measured as a function of temperature. The plot that come out of TGA is
called thermogram. A typical TGA consists of an oven with a platinum thermocouple and a
microgram balance as represented in Figure (30). A thermocouple that is made of platinum is
used to measure the temperature. The change in weight is recorded from the beam deflection. 89.
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Figure 30:Schematic diagram of TGA89.
2.12.I. Folin–Ciocalteu (FC) method
The Folin Ciocalteu method is a simple spectroscopic method for determination of phenolic
contents in herbal extracts and EOs61. Folin Ciocalteu reagent is typically composed of 100 g of
sodium tungstate (VI) dihydrate and 25g of sodium molybdate (VI) dihydrate dissolved in
700mL distilled water. Then, the formed solution is added to 100mL concentrated hydrochloric
acid and 50mL of 85% phosphoric acid added to it 150g of lithium sulphate hydrate90. The net
results of the previous addition is the formation of phosphomolybdic and phosphotungstic acids
(oxidation states of molybdenum and tungsten are 6+). The mechanism of FC reagent in
determining the amount of phenolic contents depends on the chemical reaction between FC
reagent with a reductant such as phenolic compound that forms molybdenum blue and tungsten
blue that are measured through UV-Vis spectroscopy at a wavelength of 765 nm. The reaction is
accelerated by increasing the pH of the medium by the addition of sodium carbonate91. The F-C
method was found to be beneficial in in estimating the total phenolic content (TPC) rather than
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High Performance Liquid Chromatography(HPLC), owing to its equivalent response to different
phenolic substances92. For instance, HPLC estimated only 10% of the TPC in Eucalyptus leaf
that is estimated by FC reagent93. However, the F-C method has an ability to react with nonphenolic compounds such as with tertiary aliphatic amines, sugars and inorganic reducing
agents94.
2.12.J. Ultraviolet/Visible spectroscopy (UV-Vis spectroscopy)
UV-Vis spectroscopy is a technique that is used mainly for quantitative as well as qualitative
analysis. It depends on the absorbance of a molecule to UV and Visible radiations that are part of
the electromagnetic spectrum. These radiations have energy that ranges from 36 to 143 kcal/mol
which are enough for electrons transition from the ground state to an excite state. The energy of
the UV and visible electromagnetic radiations can be calculated using equation (12)95:
E= h. ν.

(12)

Where, (E) is the radiation energy, (h) is Plank’s constant and (v) is the radiation frequency.
The wavelength at which maximum absorbance occurred which is called λmax is characteristic for
different chemical species that makes UV-Vis spectroscopy a reliable qualitative method of
analysis. Furthermore, UV/Vis spectroscopy can be used for quantitative analysis based on Beer
Lambert law shown in equation (13)95:
A = εbc

(13)

Where, (A) is the absorbance, (ε) is the absorptivity coefficient which is characteristic for each
substance, (b) is the path length of radiation that passes through a cuvette containing the sample
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and finally (c) is the sample concentration. Accordingly, through instrumental measurement of
the sample absorbance, sample concentration can be estimated95.
A typical UV/Vis spectrophotometer as represented in Figure (31) consists of; (i) a radiation
source either a deuterium lamp (for UV radiation wavelength that ranges between 200-400 nm)
or a tungsten-halogen lamp (for Vis radiation wavelength that ranges between 400-800 nm), (ii)
monochromator either grating or a prism to select only part of the electromagnetic radiation to
reach the sample, (iii) a sample holder either plastic cuvettes (for Visible radiation range) or
quartz cuvettes (for UV and Visible radiation range) and finally (iv) a detector either
photomultiplier tube detector or photodiode are used to convert the transmitted light beam into
an electrical signal95.

Figure 31:UV-Vis spectrophotometer95
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2.12.K. Antibacterial Assessment by Agar dilution and colony counting method
The agar dilution method is one of the methods that uses an antibiotic sensitivity test. In brief, an
antimicrobial agent is incorporated into a molten agar medium that contains the incubated
bacteria. The mixture is incubated while shacking under specific conditions of temperature,
speed and duration. Serial dilutions are prepared from the incubated mixture and the desired
dilution is spread on nutrient agar. Agar plate is cultured and the colonies are quantified as
represented in Figure (32). This method is commonly used for antibacterial testing against both
Gram-positive and Gram-negative bacteria96. The agar dilution method is considered a gold
standard technique of antimicrobial susceptibility testing that is characterized by its accuracy in
determination of the minimum inhibitory concentrations (MICs), and the ability to extend the
antimicrobial concentration as far as required. On the other hand, agar dilution method is an
expensive method as it requires large amount of manual handling that needs extensive training of
personnel97.
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Figure 32:Agar dilution and colony count method96

2.12.L. DPPH test
DPPH is a stable radical and has a violet color with a maximum absorbance at a wavelength of
517 nm in ethanolic solution. When DPPH comes in contact with another radical (an antioxidant)
it gets reduced. The reduced form of DPPH loses its properties as a free radical and accordingly
changes its color to yellow as represented in Figure (33). DPPH assay is easy and rapid way for
investigating the antioxidant properties. However, DPPH is not a peroxyl-radicals (physiological
radical), therefore Light, O2, and pH can influence the DPPH absorbance. Furthermore,
compounds as carotenoids with absorption wavelength of 517 nm can interfere with the
absorption maximum of DPPH.
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Figure 33:DPPH assay principle98

Chapter 3
Results and Discussion:
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Chapter 3: Results and Discussion– Chitosan/ (Peppermint and Green Tea Oil)
Nanoparticle Formulations, Characterization and in-vitro Release.

3.1. Compositional Analysis of PO and GTO by GC/MS/MS.
PO is a pale-yellow liquid obtained by steam distillation of leaves that comes from Labiatae
herbs family such as Mentha piperita L. and M. arvensis var. piperascens99. GTO on the other
hand is a yellow liquid obtained by steam distillation of leaves that comes from Theaceae herbs
family such as Camellia sinensis100. Both liquids are freely soluble in ethanol.
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The Gas Chromatography coupled to Tandem Mass Spectrometry (GC/MS/MS) technique was
used to assure the identity and to identify the components of both PO and GTO75. GC/MS/MS
chromatogram obtained from PO is illustrated in appendix I. Based on the results of GC/MS/MS
chromatogram, Citronellol is the most abundant compound in PO which is characteristic
oxygenated monoterpene phytochemical in Labiatae herbs family101. Furthermore, other
oxygenated monoterpenes were identified such as menthone, tetrahydrocarvone, menthol,
levomenthol, α-terpineol and pulegone which are characteristic for peppermint herbs102. Based
on the results revealed by GC/MS/MS chromatogram of PO, it was found that about 70.32% of
PO components are non-phenolic oxygenated monoterpenes phytochemicals as shown in Figure
(34).These results are agreed to (Gharib et al., 2013)103 findings who found about 62.2% of PO
composition was non-phenolic oxygenated monoterpenes phytochemicals.

Figure 34:Chemical structures of PO and GTO phytochemicals32.
On the other hand, according to the results of GC/MS/MS chromatogram of GTO which
are represented in appendix II, 4-chromanol is the most abundant compound (54.8%) in GTO
which is composed of a characteristic ring in the structure of phenolic flavonoids in Theaceae
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herbs family specially green tea as represented in Figure (34)104. Furthermore, fatty alcohol such
as oleic alcohol were identified in the MS chart of GTO that is characteristic in green tea
herbs105. These
findings were found to be similar to the findings of (Packer, 2001)104 who reported that the 4chromanol ring is a fundamental component of tea flavonoids such as Quercetin and Epicatechin.
In this regard, the results of GC/MS/MS chromatogram for both EOs agree to a large extent with
previously published reports and confirm the identity and characteristic components for both PO
and GTO and shed light on the clear difference in the origin and composition of the both EOs.

3.3.A. Impact of homogenization parameters on the average size and zeta potential of
CS/PO NPs.
As reported previously, homogenization parameters such as speed and duration had crucial role
in reducing the average size of different NPs by increasing the rotor stator homogenizer speed
and duration 106,107. CS/PO NPs were prepared by using a ratio of CS to PO (1:1) with fixed TPP
concentration at 0.5%w/v. Different homogenization speeds (12000, 13000 and 14000 rpm) at
different homogenization times (5, 10 and 15 min) were used.
As shown in Figure(35a), homogenization speed had a significant impact on particle size
diameter. Increasing the homogenization speed was identified to significantly reduce the NPs
diameter. For instance, at 10 min homogenization, the average diameter of the NPs at 12000,
13000 and 14000 rpm were 549.9

11.08, 420.1

9.77 and 404.8

5.45 nm, respectively. On

the other hand, homogenization time also had an impact on the NPs diameter. So,
homogenization for 10 min showed significant lower NPs average diameter at all
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homogenization speeds. It should be noted that, at 5 min homogenization, incomplete
homogenization was noticed specifically at 12000 rpm. Based on the previous results,
homogenization at 14000 rpm that represent the higher speed with duration of 10 min showed
the lowest NPs diameter.

(a)

(b)
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Figure 35:Impact of homogenization parameters on (a) the average NPs diameter and (b) size
distribution of CS/PO NPs.
As shown in Figure (35b), homogenization speed had a significant impact on the NPs size
distribution. The highest NPs size mono-dispersity (lowest PDI) was identified at
homogenization speed of 14000 rpm at all homogenization times while homogenization speed of
13000 rpm showed the lowest NPs size mono-dispersity (highest PDI) at all homogenization
times as well. For instance, at 10 min homogenization, the PDI value at 12000, 13000 and 14000
rpm were 0.34

0.01, 0.37

0.01 and 0.22

0.02, respectively. On the other hand,

homogenization time also had an impact on the NPs diameter. So, homogenization for 5 min
showed the highest PDI value at all homogenization speeds, while, homogenization for 10 min at
14000 rpm showed the lowest PDI value. Based on both average NPs size and PDI results,
homogenization at 14000 rpm for 10 min showed the ideal homogenization parameters.
Surprisingly, previous reports agree with our findings and recommended a 10min
homogenization at 14000 rpm as an optimum homogenization condition in encapsulation of
Oregano, Carum copticum and Carvacrol in CS-TPP system61,76,108. It should be pointed out that
any further increase in homogenization speed was not favorable, because of the high energy
provided to the medium which led to volatilization of EO, particle aggregation and enlargement
rather than particle size reduction106.
3.3.B. Impact of TPP concentration on the average size and zeta potential of
CS/PO NPs
Based on the homogenization parameters studies, new batches were prepared using
homogenization speed of 1400 rpm in a duration of 10 min to study the impact of TPP
concentrations on the NPs size, size distribution and zeta potential. Different TPP concentrations
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were used ranging from 0.3-1% w/v. According to Figure (36a), the NPs size first gradually
decreased from 300

7.52 nm to 238.9 9.56 nm at TPP concentration of 0.4 %w/v and then

increased dramatically to 720.3 13.8 nm at TPP concentration of 1% w/v. Based on these
results, the TPP concentration of 0.4%w/v showed the lowest NPs size.

(a)
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(b)

Figure 36: Impact of TPP concentrations on (a) the NPs size and size distribution (b) the zeta
potential of CS/PO NPs.
According to NPs mono-dispersity, as shown in Figure (36a), increasing the concentration of
TPP showed a statistically no change in PDI value reaching 0.29

0.003 nm at TPP

concentration of 0.4% w/v, then a significant increase in PDI value reaching 0.339

0.01 nm

that appeared at TPP concentration of 1%w/v. Based on these results, the TPP concentration of
0.3 to 0.4%w/v showed statistically no change in mono-dispersity of the NP size.
As shown in Figure (36b), increasing the concentration of TPP showed a significant increase in
zeta potential (ZP) value reaching 23.15

1.05 mV at TPP (0.4% w/v). The reason behind this

elevation in ZP value at the concentration of TPP below (0.4 % w/v) might be due to the
formation of more tightly compacted NPs. TPP is a cross-linker with negative charge that
minimizes the electrostatic repulsion between CS molecules and thus enhances the aggregation
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and NP formation76. As the NP forms, additional incorporation of TPP is suggested to increase
the internal cross-linking between CS chains within the NP, leading to the formation of more
tightly bound CS chains that increase the surface area per unit volume of the particle thus
increasing the exposed charges on NPs surface. On the other hand, increasing the concentration
of TPP more than 0.4% w/v results in dramatical decrease in ZP value to 11.29

1.21 mV that

appeared at TPP concentration of 1%w/v. The reason behind that is might be due to the
neutralization of the majority of the CS protonated amino groups by TPP anions that enhance
hydrogen bonding interactions between the formed NPs and that might be a reason for the
dramatic size enlargement of the NPs109,110.111. Based on these results, the TPP concentration of
0.4%w/v showed the most significant stable NPs.
Based on the previous experiments, the ideal conditions for the preparation of the CS/PO NPs
were homogenization speed of 1400 rpm for 10 min with TPP concentration of 0.4%. After
establishing the optimum preparation conditions, different ratios of CS to PO and GTO were
used (1:0.25, 1:0.50, 1:0.75 and 1:1.00 w/w) followed by NPs characterization, encapsulation
efficiency determination, in-vitro release and stability of phenolic contents in the NPs as will be
described in the following sections.
3.4. Characterization of nanoparticles formulations of EOs.
3.4.A. Nanoparticles hydrodynamic size
Nanoparticles hydrodynamic size were studied using dynamic light scattering (DLS) technique
(Zetasizer). As represented in Figure (37), chitosan nanoparticles (CS NPs) possessed an
average diameter of 217.2

6.42 nm. On the other hand, CS/PO NPs with CS to PO ratio of

(1:0.25, 1:0.50, 1:0.75 and 1:1.00 w/w) showed an average diameter of 231.4
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12.72, 249.7

2.78, 252.6

3.48 and 238.9

9.56 nm, respectively. Results revealed that the mean particle

size increased significantly as initial PO content increased until 252.6

3.48 nm at CS/PO ratio

of 1:0.75 w/w. Finally, the size tended to decrease at CS/PO ratio of (1:1.00 w/w) samples to
238.9 9.56 nm.
GTO-loaded CS NPs (CS/GTO NPs) with CS to GTO ratio of (1:0.25, 1:0.50, 1:0.75 and 1:1.00
w/w) showed an average diameter of (226.3

4.9, 240.9

7.33, 249.7

28.75 and 237.5

15.69 nm, respectively as represented in Figure (37). In contrast to PO, the mean particle size
showed statistically no change with increased initial GTO content until 249.7

28.75 nm at

CS/GTO ratio of (1:0.75 w/w).
Both EOs showed a maximum NPs size at a ratio of CS/EO (1:0.75 w/w). The previous results
showed statistically no change in sizes between the two EOs with different concentrations
revealing the independency of CS NP hydrodynamic diameter on the type of EO.

These results are agreed with the (Hosseini et al., 2013)108 findings who found that the average
diameter of the NPs increased form 281 nm to 402 nm after encapsulation of Oregano in CS-TPP
system. Furthermore, (Yoksan et al., 2011)76 revealed the size increase of NPs from 518 nm to
716 nm after encapsulation of Carvacrol in CS-TPP system. However, these findings contradict
the results of (Feyzioglu et al., 2016)63 who found a reduction in the NPs size from 237 nm to
140 nm after encapsulation of summer savory in CS-TPP system. So, in our work, a possible
reason behind the size increase of the NPs diameters in both EOs might be due to the swelling
and aggregation of CS polymer while dispersed in water76.
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According to the size distribution of both CS/PO NPs and CS/GTO NPs with their different
concentrations, The PDI values ranged from 0.22 – 0.25 and from 0.24 – 0.25 in CS/PO NPs and
CS/GTO NPs, respectively. Increasing the PO and GTO content had a non-significant impact on
the PDI value. Furthermore, the previous results showed statistically no change in PDI between
both PO and GTO revealing the independency of CS NP size distribution on the type of EO. The
above data are represented in appendix III.

Figure 37:Z-average diameter of nanoparticles as a function of initial PO and GTO content.
3.4.B. Zeta potential of nanoparticles.
Zeta potential (ZP) studies were performed to show the impact of EOs loading on the surface
charge and stability of the prepared NPs. As represented in Figure (38), CS NPs gave a ZP value
of +24.9

0.95 mV. On the other hand, CS/PO NPs showed ZP values of (20.95

20.9 0.23, 21.2

0.98 and 23.15

0.66,

1.05 mV for CS/PO ratio of (1:0.25, 1:0.50, 1:0.75 and

1:1.00 w/w) respectively. Results indicated that increasing the PO content reduced significantly
the value of ZP. The higher ZP value of PO loaded CS NP that showed the highest stability
occurred with CS/PO ratio (1:1.00 w/w).
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On the other hand, CS/GTO NPs showed ZP values of (24.2
17.8

0.3, 21.3

0.4, 24.5

1.64 and

0.4 mV) for CS/GTO ratio of (1:0.25, 1:0.50, 1:0.75 and 1:1.00 w/w) respectively, as

represented in Figure (38). Results indicated that increasing the GTO content reduced
significantly the value of ZP. CS/GTO ratio (1:0.75 w/w) showed the highest stability. Based on
previous results, statistically no change in ZP between the two EOs with different concentrations
revealing the independency of CS NPs surface charge on the type of EO.
These results were found to be in agreement with the findings of (Haider et al., 2017)56 in the
encapsulation of krill oil in CS-TPP system who found a reduction of ZP from +35 mV to +24
mV. Moreover, the encapsulation of eugenol in CS-TPP system (Woranuch et al., 2013)53
showed a decrease in ZP value from +37 mV to +16 mV. So, in our case, a possible reason
behind the reduction in ZP in both EOs might be due to a shielding effect and the coating of
protonated NH2 group by PO and GTO on the CS NPs76. The decrease in ZP value enhances the
attractions between the formed NPs that might be a possible reason behind the increase in the
average diameter in comparison with the CS NPs with increasing PO63.
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Figure 38:Zeta potential of CS NPs as a function of initial PO and GTO content.
3.4.C. Morphology of nanoparticles.
The size and morphology of the NPs was examined by transmission electron microscope (TEM).
CS NPs, CS/PO NPs (1:1 w/w) and CS/GTO NPs (1:1 w/w) appeared as spherical shapes as
shown in Figure (39). The difference in shape between the nanoparticles were insignificant
revealing the independency of CS NPs shape and morphology on the type of EO. This was found
to be in agreement with the findings of (Yoksan et al., 2011)76 in the encapsulation of carvacrol.
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Figure 39: TEM of spherical nanoparticle, CS NP (a), CS/PO NP (1:1) (b) and
CS/GTO NP (1:1) (c).
As represented in the size distribution histograms (Figure 40), the size range of CS NPs, CS/PO
NPs and CS/GTO NPs were between 10-90 nm, 20-90 nm and 10-70nm, respectively.
Furthermore, the estimated average size for CS NPs, CS/PO NPs and CS/GTO NPs were 36.1
nm, 43.5 nm, and 30.7 nm, respectively. The encapsulation of PO increased significantly the size
of the CS/PO NPs compared with CS NPs while the encapsulation of GTO reduces significantly
the size of the CS/GTO NPs compared with CS NPs.

Figure 40: Size distribution histograms of the prepared nanoparticles, CS NP (a), CS/PO NP
(1:1) (b) and CS/GTO NP (1:1) (c).
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However, most of our NPs (CS NPs, CS/PO NPs and CS/GTO NPs) were aggregated as shown
in Figure (41) that might be due to be a fusion and combination of the CS/PO NPs and CS/GTO
NPs with each other as well as PO and GTO content on the surface of the particle similar to what
was previously reported by (Yoksan et al., 2010)112

as represented in Figure (42) after

encapsulation of carvacrol in CS NPs .

Figure 41:TEM of aggregated nanoparticle, CS NP (a), CS/PO NP (1:1) (b) and
CS/GTO NP (1:1) (c).

Figure 42:TEM of aggregated CS/ Carvacrol nanoparticle76.
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It should be figure out that the mean average size of all nanoparticles that estimated by zetasizer
was greater than that detected by TEM. This is mainly because the size that is determined by
zetasizer is a hydrodynamic size where the NPs are suspended in solutions that enhances the
aggregation of the NPs as mentioned before76.
3.4.D. Fourier transform infra-red (FT-IR) spectroscopy analysis of CS, EOs and NPs
Fourier transform infra-red (FTIR) spectroscopy analysis was used to study the chemical
characteristics of pure PO, CS NPs and CS/PO NPs (with ratios of 1:0.25, 1:0.5, 1:0.75 and
1:1.00 w/w). FTIR spectra of CS NP (Figure 43a) showed characteristic peaks at 3433 cm-1 due
to hydroxyl group and primary amine stretching. Sp3 C-H stretching appeared at 2933 cm-1 while
amide stretching peaks appeared at 1642 and 1550 cm-1. In addition, pure PO spectra (Figure
43b) showed sharp characteristic peaks at 2929 cm-1 due to Sp3 C-H stretching and at 1710 cm-1
due to carbonyl stretching. All the characteristic peaks of both CS NP and pure PO were
appeared in the spectra of CS/PO NPs (Figure 43c, d, e and f) with carbonyl stretching peak that
increased with increasing PO content and all peaks were shifted from 1710 cm-1 to 1731 cm-1.
The results of FTIR identify the incorporation of PO in the CS-TPP system.
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Figure 43: FT-IR of CS NP(a), pure PO (b) and CS/PO NP (c-f) with different ratios of CS: PO
1:0.25 (c), 1:0.50 (d), 1:0.75 (e) and 1:1.00 w/w (f).
In the case of CS NPs loaded with GTO, pure GTO spectra (Figure 44b) showed sharp
characteristic peaks at 2929 cm-1 due to Sp3 C-H stretching and at 1731 cm-1 due to carbonyl
stretching. All the characteristic peaks of both CS NP and pure PO were appeared in the spectra
of CS/GTO NPs (Figure 44c, d, e and f) with carbonyl stretching peak that increased with
increasing GTO content at the same wave number. The results of FT-IR identify the
encapsulation of GTO in the CS-TPP system.
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Figure 44:FT-IR of CS NP(a), pure GTO (b) and CS/GTO NP (c-f) with different ratios of
CS: GTO: 1:0.25 (c), 1:0.50 (d), 1:0.75 (e) and 1:1.00 w/w (f).
3.4.E. Thermal gravimetric analysis (TGA) of CS, EOs and NPs
TGA analysis was performed as represented by Figure (45) to study the thermal stability of both
essential oil and nanoparticles.
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Figure 45:TGA thermogram of CS/PO NP (A) and CS/GTO NP (B): pure EO (a), CS NP (b)
and CS/EO NP (c-f) with different ratios of CS: EO 1:0.25 (c), 1:0.50 (d), 1:0.75 (e)
and 1:1.00 w/w (f).
The temperature at which material subjected to a highest rate of weight loss is called degradation
temperatures (Td) that is identified from estimating the first derivative of the TGA curve at the
higher significant weight change which is called derivative thermogravimetry (DTG)
thermogram Figure (46).
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Figure 46:DTG thermogram of CS/PO NP (A) and CS/GTO NP (B): pure EO (a), CS NP (b)
and CS/EO NP (c-f) with different ratios of CS: EO 1:0.25 (c), 1:0.50 (d), 1:0.75 (e)
and 1:1.00 w/w (f).
TGA thermogram of pure PO and GTO showed one mass loss step started at 50 °C (Figure 45Aa and 45 B-a) respectively. The degradation temperatures (Td) of pure PO and pure GTO were
160 °C and 200 °C as shown in Figure (46 A-a) and Figure (46 B-a). The previous results
indicate the lower thermal stability of both EO.
On the other hand, CS NPs exhibited two-step mass loss (Figure 45 A-b) at 90 °C due to the
evaporation of moisture and at 250 °C (Figure 46A – b) assigned to dehydration and
decomposition of the CS56,108,113.
CS/GTO NPs exhibited a new step mass from 90-180 °C (Td of 140 °C) due to decomposition of
free GTO that might be adsorbed on the surface of NPs, which was found to be in agreement
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with the finding of (Yoksan et al., 2011)76 who found that the free carvacrol that adsorb on the
surface of CS NPs had a Td of 185

62

.

Surprisingly, both CS/PO NPs and CS/GTO NPs with different concentrations exhibited new
step mass loss from 280 to 380 °C (Figure 45 A and B (c-f)) with a degradation temperature
(Td) of (340-350 °C) for both NPs as represented in Figure (46 A and B (c-f)). The new step
mass loss may reflect the encapsulated PO and GTO which degraded at higher temperature.
These results are in a good agreement with the findings of (Hosseini et al., 2013)108, (Yoksan
et al., 2011)62 and (Wu et al., 2005)114. All these previous reports showed a degradation
temperature ranged between 320 to 340 °C after encapsulation of oregano and ammonium
glycyrrhizinate in CS-TPP nanoparticles.
Encapsulated PO and GTO decomposed at 350 °C than free PO and GTO that were decomposed
at 160 °C and 200 °C, respectively reflecting the significant improvement of the thermal stability
3.4.F. Powder X-ray Diffraction (XRD) analysis of CS, and NPs
The crystallographic structure of CS powder, CS NPS, CS/PO NPs and CS/GTO NPs were
determined by XRD as shown in Figure (47). CS powder exhibits two characteristic peaks: first
peak at 2 of 10o and second peak at 20o indicating a higher degree of crystallinity which is
similar to what was previously reported by (Yoksan et al., 2011)62 and (Hosseini et al., 2013)108.
However, no peak is found in case of CS NPs after TPP cross linking indicating destruction of
native crystalline packing structure of CS powder after preparation of CS NPs which was found
to be similar to what was previously reported by (Yoksan et al., 2010)113, (Jingou et al., 2010)115
and (Hosseini et al., 2013)108. Diffraction pattern of CS/PO NPs and CS/GTO NPs (1:1.00)
shows an observed broad peak at 2

ranged between 15o-24o more than that in CS NPs
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confirming encapsulation of PO in CS NPs which is agreed to the findings of (Hosseini et al.,
2013)108.

Figure 47: XRD pattern of CS powder (a), CS NPs (b), CS/GTO NPs (1:1 w/w) (c) and
CS/PO NPs (1:1 w/w) (d).
3.5. Determination of the Encapsulation Efficiency (EE%) and loading capacity (LC%) of
NPs.
For estimating the amount of both GTO and PO that encapsulated in NPs, UV–Vis
spectrophotometry were used. The amount of encapsulated PO was estimated from measuring of
the absorbance PO at the wavelength of (227 nm) according to (Deka et al., 2016)77 as
represented in Figure (48 A).
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Figure 48:UV–Vis spectra of CS/PO NP (A) and CS/GTO NP (B): CS NPs (a) and CS/EO NPs
(b-e) with different ratios of CS: EO 1:0.25 (c), 1:0.50 (d), 1:0.75 (e)
and 1:1.00 w/w (f).
Standard calibration curve of PO in concentration between (0.1 to 0.7 mg/mL) in ethanol was
prepared and a regression line with R2 of 0.999 was achieved as shown in Figure (49 A).

Figure 49:Calibration curve of (A) PO in ethanol and (B) GTO in ethanol.
Encapsulation efficiency (EE%), which is the ratio of encapsulated PO to total PO108, in CS/PO
NPs with PO concentration of 0.25, 0.50, 0.75 and 1.00 (w/w CS) showed an EE% of (82.1
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7.55, 79.4

4.1, 76.7

1.3 and 78.4

1.95 %). The EE% results (Figure 50A) showed that

statistically no change in EE% with increasing the PO content .On the other hand, the loading
capacity (LC%), which is the ratio of encapsulated PO to the total weight of NPs108, in CS/PO
NPs with PO concentration of 0.25, 0.50, 0.75 and 1.00 (w/w CS) showed an LC% of
(8.15 0.75, 13.1 0.74, 17.6 0.5 and 22.2

0.55 %) as represented in Figure (50A). The

results indicated that LC% enhanced with increasing the initial PO content. Maximum EE%
identified at CS/PO ratio of 1:0.25 w/w while maximum LC% appeared at ratio of 1:1 w/w.

Figure 50: EE% and LC% of (A) CS/PO as a function of initial PO content and (B) CS/GTO as
a function of initial GTO content
The amount of encapsulated GTO was estimated from the absorbance at the wavelength of (274
nm) according to (Pan et al., 2016)116 as represented in Figure (48 B). Standard calibration curve
of GTO in concentration between (30- 200 g/mL) in ethanol was prepared and a regression line
with R2 of 0.996 was achieved as shown in Figure (49 B). The EE% in CS/GTO NPs with GTO
concentration of 0.25, 0.50, 0.75 and 1.00 (w/w CS) showed an EE% of (22.13
3.32, 59.12

2.96 and 81.46

7.36, 58.72

5.76). The EE% results showed that increasing the GTO content
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up to the ratio of (1:1 w/w) led to an increase in EE% as shown in Figure (50B). On the other
hand, the LC% in CS/GTO NPs with GTO concentration of 0.25, 0.50, 0.75 and 1.00 (w/w CS)
showed an LC% of (2.2

0.72, 10.6

0.6, 13.08

0.75 and 23.14

1.63 %) as represented in

Figure (50B). The results indicated that LC% increased with increasing in GTO content.
Maximum EE% and LC% identified at CS/GTO ratio of 1:1.
EE% results showed that increasing the PO content up to the ratio of (1:0.75 w/w) led to a
decrease in the EE% that might be as a result of the encapsulation limitation of PO in CS-TPP
system, which was found to be in agreement with the findings reported on the encapsulation of
ascorbyl palmitate (Yoksan et al., 2010)113 and Oregano (Hosseini et al., 2013)108. On the other
hand, EE% results showed that increasing the GTO content up (1:1.00 w/w) led to an increase in
EE% .Furthermore, the LC% of both GTO and GTO enhanced with increasing the initial PO and
GTO content, respectively which is in agreement with the findings reported on the encapsulation
of ascorbyl palmitate by (Yoksan et al., 2010)113 and Oregano (Hosseini et al., 2013)108.
3.6. In-vitro release studies of NPs
The in-vitro release study of PO from CS/PO NPs (1:1.00 w/w) NPs was carried out for 96 hours
in different pH media (3 and 7.4) to confirm the successful encapsulation of PO, and to
determine the rate of PO releasing from the NPs. Based on the release rate, the release profile of
PO showed three different release stages, as represented in Figure (51). The initial burst release
was observed for the first 6 hours, PO was released up to 34.8

1.63 % and 40.7

0.73 % in

acetate buffer of (pH 3), and phosphate buffer saline (PBS) of (pH 7.4), respectively. A
significantly decreased in release rate was observed in the second stage (from 6 hours to 72
hours), PO was released up to 50.7

0.24 % and 61.3

4.93 % in acetate buffer and PBS,

respectively. The final stage (from 72 hours to 96 hours) showed the release of PO reaching
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plateau at this stage and PO was released up to 52.7

0.24% and 63.3

3.9 % in acetate buffer

and PBS, respectively. The amount of PO released was affected by the pH of the media. At
acidic media (pH 3), PO was released from CS NPs rapidly than at higher pH media (pH 7.4).

Figure 51:In-vitro release profiles of PO from CS/PO NPs (1:1) in different pH media:
pH 3 and pH 7.4.
The in-vitro release study of GTO from CS/GTO NPs (1:1.00 w/w) NPs was carried out for 72
hours in different pH media (3 and 7.4). Based on the release rate, the release profile of GTO
showed three different release stages, as represented in Figure (52). The initial release was
detected for the first 6 hours, GTO was released up to 66.7

11.28 % and 53.8

8.89 % in

acetate buffer and PBS, respectively. The release rate significantly decreased for the second
stage (from 6 to 12 hours), GTO was released up to 74.5

12.75 and 62.97 9.17 % in acetate

buffer and PBS, respectively. The final stage (from 12 hours to 72 hours) showed the release of
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GTO reaching plateau at this stage and GTO was released up to 74.9

10 and 63.1

8.83 % in

acetate buffer and PBS, respectively. Similar to PO release profile, the amount of GTO released
was affected by the pH of the media. At acidic media (pH 3), GTO was released from CS NPs
rapidly higher pH media (pH 7.4).

Figure 52: In-vitro release profiles of GTO from CS/GTO NPs (1:1.00) in different pH media:
pH 3 and pH 7.4.
At represented in the previous results, the amount of PO and GTO released was affected by the
pH of the media. At acidic media (pH 3), both PO and GTO were released from CS NPs very
quickly, and the released PO and GTO contents were significantly higher than that occurs at
higher pH media (pH 7.4) which is most probably due to the swelling and partial dissolution of
the NPs that are shown in Figure (53)62.
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Figure 53:Impact of pH of the release media on CS-TPP system76.
It should be pointed out that the released PO and GTO were not completely released from NPs
because complete release needs complete degradations of CS NPs. The release results agreed to
the findings reported on the release of carvacrol from CS-TPP system (Yoksan et al., 2011)62.
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3.7. Stability of phenolic contents in CS NPs
To investigate antioxidant activity of both PO and GTO, electron-transfer reaction including the
total phenolic assay using Folin–Ciocalteu reagent was used61.
In the case of PO, each gram was equivalent to 1.15
each gram of GTO was equivalent to 7.15

0.01 mg GAE, while, on the other hand,

0.29 mg GAE, which is about 6.21 folds increase in

TPC, as shown in Figure (54). This significantly higher TPC in GTO over PO is basically due to
the difference in the origin and composition of both EOs which was also confirmed by the
GC/MS/MS findings of both EOs.
To study the ability of CS NPs to maintain the stability of phenolic contents of both PO and
GTO; the CS NPs, CS/PO NPs and CS/GTO NPs were assayed for their TPC using Folin–
Ciocalteu reagent for 6 hours. As shown in Figure (54). CS NPs, CS/PO NPs and CS/GTO NPs
has TPC of 0.06

0.01, 1.08

0.01 and 7.39 0.29 mg gallic acid, respectively.

TP content that arise for CS NPs might be explained by chromogenes that formed after the
reaction between CS and Folin–Ciocalteu reagent as previously reported by (Esmaeili et al.,
2015)117, (Moradi et al., 2012)118 and (Ruiz-Navajas et al., 2013)119.
Both CS/PO NPs and CS/GTO NPs have significantly higher TPC than CS NPs. On the other
hand, the TPC that identified for encapsulated PO is significantly lower than free PO that might
be due to slow release profile of PO as mentioned in the in vitro analysis section which agree
with the findings of (Esmaeili et al., 2015)117. On the other hand, for encapsulated GTO showed
statistically no change in the TPC than free GTO. Based on these results, CS NPs can maintain
the stability of TPC.
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Figure 54:TPC of CS NPs, PO, GTO, CS/GTO NPs and CS/PO NPs
expressed in (mg GAE/g oil).
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Chapter 4: Antioxidant and antibacterial activities of Chitosan/ (Peppermint and Green
Tea Oil) Nanoparticle
4.1. Evaluation of antioxidant activity of EOs NPs
DPPH assay was one of the suitable methods to determine the antioxidant activity of the EO and
their CS NPs counterparts in an in-vitro condition. DPPH molecule (Figure 55) has the
capability to oxidize molecules by acting as hydrogen ion acceptor. Thus, this assay was used to
estimate the antioxidant activity of many EOs formulations117,120.

Figure 55: Mechanism of DPPH oxidation120.
According to Figure (56), DPPH radical scavenging ability was identified for predetermined
CS/PO NPs and corresponding PO and CS NPs amounts. CS NPs have antioxidant activity that
ranges between 9.3 to 21.13% for concentration ranges between 6 to 48 mg/mL respectively. On
the other hand, both CS/PO NPs and corresponding amounts of pure PO (range between 0.4 –
3.5 mg/mL) show a concentration-dependent antioxidant activity (Figure 56) and were in the
range of 24.4 - 71.4 and 13 to 52.3%, respectively.
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Figure 56: DPPH inhibition (%) of pure PO, CS NPs and CS/PO NPs.
Furthermore, DPPH radical scavenging ability was identified for predetermined CS/GTO NPs
and corresponding GTO and CS NPs amounts. CS NPs have antioxidant activity that ranges
between 5 to 18 % for concentration ranges between 2.5 to 20.1 mg/mL respectively that shows a
limited antioxidant activity as mentioned above. It should be pointed out that the difference in
CS NPs % DPPH inhibition between CS/PO system and CS/GTO system is due to using
different concentration range of CS NPs due to the difference in % DPPH inhibition of pure PO
and GTO. On the other hand, both CS/GTO NPs and corresponding amounts of pure GTO
(range between 0.19 – 1.58 mg/mL) show a concentration-dependent antioxidant activity
(Figure 57) and were in the range of 45.9 – 94.2 and 26.9 to 73.1%, respectively.

92

Figure 57:DPPH inhibition (%) of pure GTO, CS NPs and CS/GTO NPs.
Based on the previous results, the IC50 (concentration required to scavenge DPPH radicals by
50%) was calculated for PO, GTO, CS, CS/PO NPs and CS/GTO NPs as shown in Table (9).
Table 8: IC50 of antioxidant activities of PO, GTO, CS NPs, CS/PO NPs and CS/GTO NPs.
IC50 (mg/mL)

Sample
PO

3.25

GTO

0.81

CS NPs
CS/PO NPs

116.07
22.20 (1.61 mg/mL for corresponding PO)

CS/GTO NPs 4.40 (0.34 mg/mL for corresponding GTO)
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As represented in (Table 8), CS/NPs showed a limited antioxidant activity (IC50) of 116.07
mg/mL that agrees to the findings of (Chen et al., 2009)78 and (Esmaeili et al., 2015)117. The
reason behind that might be related to the CS, TPP crosslinking which masks the CS amino
groups responsible for the reaction with DPPH molecules as was mentioned by (Xie et al.,
2001)121, (Chen et al., 2009)78, (Barzegar et al.,2016)122 and (Esmaeili et al., 2015)139. On the
other hand, bulk PO and GTO showed antioxidant activities (IC50) of 3.25 mg/mL and 0.81
mg/mL. It should be noted that the antioxidant activity of pure GTO was significantly higher
than PO by about 4 folds. The reason behind that might be due to the impact of phenolic contents
that are found in higher amount in GTO than PO as mentioned in chapter 4. To enhance the
antioxidant activity of both bulk EOs, nano-encapsulated EOs were tested against DPPH.
Surprisingly, the antioxidant activity of encapsulated PO was significantly higher than free PO
by 2 folds. However, the antioxidant activity of PO was not significantly higher than CS NPs.
Similarly, the antioxidant activity of encapsulated GTO was improved significantly than free
GTO and by ~2.4 folds. The antioxidant activity findings of both EOs agree with the findings of
(Barzegar et al.,2016)122 in enhancement of the antioxidant activity of encapsulated thyme oil in
CS NPs by 24.45%, and (Woranuch et al., 2013)53 in the improvement of scavenging activity of
loaded eugenol in CS NPs by 2.7 fold, in addition to (Lee et al., 2011) in an increase of DPPH
inhibition of astaxanthin in calcium alginate gel beads. The reason behind this improvements in
case of PO and GTO NPs might be due to the protective effect of encapsulation that decreases
evaporation rate via controlled release of PO and GTO during the assay that was identified by
(Barzegar et al.,2016)122 in the encapsulation of thyme oil in CS NPs.
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Based on these results, encapsulation of GTO and PO in CS NPs enhanced the antioxidant
activity of free GTO and PO, respectively. Furthermore, CS/GTO NPs showed a significant
higher antioxidant activity than CS/PO NPs by about 4.7 folds.
5.2. Evaluation of the antibacterial activity of EOs NPs
Agar dilution and colony counting methods were used to investigate the impact of encapsulation
of PO and GTO on the antibacterial activity against both Staphylococcus aureus (S. aureus) and
Escherichia coli (E.coli) as examples for Gram positive and Gram negative bacteria,
respectively in LB agar media (Wei et al., 2009)79. The antibacterial activity was estimated
through the reduction in numbers of the bacterial colonies after introducing the sample compared
to the positive control (LB media with bacteria only).
5.2.1. Evaluation of antibacterial activity of EOs NPs against S. aureus
As represented in Figure (58A, B), positive control shows a large number of colonies indicating
a good growth of S. aureus while the negative control shows no colonies representing the
sterility of the agar medium79. Bulk PO and GTO showed antibacterial activities of 60.2 6.12 %
and 40.54

2.36, respectively. Bulk PO and GTO antibacterial activities rely on the penetration

of phytochemical components through the phospholipid of cell membrane and the damage of
proteins and lipids39,123,124. It should be noted that the antibacterial activity of bulk PO was
significantly higher than GTO by about 19.7% which agrees with the findings of (OSAWA et al.,
1999)125. The reason behind that might be due to the presence of proteins in LB agar media that
might hinder the antibacterial activity of GTO as its polyphenols bactericidal potential relies on
the destruction of cell membranes proteins

125

. However, both bulk EOs still showed lower
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antimicrobial activity. As a trial to enhance the bactericidal activity of both bulk EOs, nanoencapsulated EOs were tested against S. aureus.
Surprisingly, encapsulated PO showed a significant enhancement of bactericidal activity by
about 39.63% over bulk PO. In the same way, a significant enhancement of the antibacterial
activity was revealed for encapsulated GTO against S. aureus by about 57.5%. It should be noted
that the maximum antibacterial activity was found in CS/PO NPs (99.9

0.1%). Therefore, the

nano-encapsulation of both bulk EOs was a magical solution for enhancing the antimicrobial
potential.
These results agree with the findings of (Esmaeili et al., 2015)117 that showed an enhancement of
the antibacterial activity of encapsulated Carum copticum essential oil (CEO) over pure CEO by
1.16 folds. On the other hand, (Yoksan et al., 2011)62 showed an antibacterial activity of
encapsulated carvacrol in CS NPs that was very close to free carvacrol. The reason behind the
enhancement of bactericidal activity of encapsulated oils might be related to the antibacterial
activity of CS NPs themselves that showed bactericidal activity against S. aureus by about 99.1
0.23%. CS NPs antimicrobial activity might be due to ionic interaction between the positive
charge on CS and the anionic surface of bacteria.
It should be noted that CS NPs, CS/PO NPS and CS/GTO NPs showed statistically no change in
antibacterial activities. Based on these results, encapsulated PO showed a maximum antibacterial
activity against S. aureus. Nevertheless, both CS/PO NPs and CS/GTO NPs could be used as an
antimicrobial agent against S. aureus.
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(A)

(B)

Figure 58:(A) % Inhibition of S. aureus and, (B) representative photographs of the bactericidal
activity toward S. aureus by PO, GTO, CS NPs, CS/PO NPs, CS/GTO NPs, negative and
positive control.
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5.2.2. Evaluation of antibacterial activity of EOs NPs against E.coli
As represented in Figure (59A, B), positive control shows a good growth of E.coli while the
negative control shows the sterility of the LB agar medium as shown with S.aureus79. Bulk PO
and GTO showed antibacterial activities of 94.53

0.53% and 97.3

0.34%, respectively. Bulk

PO and GTO antibacterial activities rely on the interaction of lipophilic oil and the phospholipid
membrane that induce passive permeability126. It should be noted that the antibacterial activity of
pure GTO was significantly higher than PO by about 2.77 %. The reason behind that might due
to the higher GTO polyphenols and their hydrophobicity which enhances their penetration ability
through cell phospholipid membranes127. In spite of the higher antibacterial activities of both
bulk EOs, a further enhancement of the bactericidal activity via nano-encapsulation was tested
against E.coli.
Similar to the antibacterial results observed with S. aureus, the encapsulated PO showed a
statistical significant enhancement of bactericidal activity by about 3.01% over bulk PO.
Similarly, a significant enhancement of the antibacterial activity was revealed for the
encapsulated GTO against E.coli by about 1.88%. Both encapsulated GTO and PO showed
antibacterial activities against E.coli that are very close to their bulk EOs. The reason behind that
might be related to the controlled release of oils as well as the antibacterial activity of CS NPs
themselves that showed bactericidal activity against E.coli by about 99.2

0.68% due to ionic

reaction between the positive charge on CS and the anionic surface of bacteria. These results
agree with the findings of (Esmaeili et al., 2015)117 that showed an 1.28 folds enhancement of the
antibacterial activity of encapsulated CEO over pure CEO.
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Figure 59: (A) % Inhibition of E.coli and, (B) representative photographs of the bactericidal
activity toward E.coli by PO, GTO, CS NPs, CS/PO NPs, CS/GTO NPs, negative and positive
control.
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It should be noted that CS NPs, CS/PO NPS and CS/GTO NPs showed statistically no change in
antibacterial activities. Based on these results, both CS/PO NPs and CS/GTO NPs could be used
as an antibacterial agent against E.coli. Furthermore, the improvement of antibacterial activity
after encapsulation of both PO and GTO in CS NPs against S. aureus is significantly higher than
that against E.coli. In other words, encapsulation of PO enhanced the antimicrobial activity
against S. aureus more than E.coli by 13.1 folds. Whereas, the encapsulation of GTO enhanced
the antibacterial activity against S. aureus more than E.coli by 30.6 folds. The reason behind that
might be due to the limited penetration of these hydrophobic EOs through hydrophilic
peptidoglycan of bacterial cell wall that is normally found in Gram positive bacteria62,117,128.
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Chapter 5: Conclusion and Future perspectives
In this study, two EOs namely; PO and GTO were encapsulated in CS NPs. Two-steps method
was used for the encapsulation of EOs in CS NPs which is oil-in-water emulsification followed
by cross-linking of CS polymer with sodium tripolyphosphate (TPP) in a process called ionic
gelation. To characterize the encapsulated EOs, different characterization techniques were used
such as; Fourier transform infrared (FT-IR) spectroscopy, powder X-ray diffraction (XRD),
thermogravimetric analysis (TGA) and UV–vis spectrophotometry. Both NPs formulations
(CS/PO NPs and CS/GTO NPs) showed a spherical shape with size range of 20-90 nm as
detected by Transmission electron microscopy (TEM). As determined by UV–vis
spectrophotometry, the EE% of CS/PO NPs and CS/GTO NPs were about 82-78% and 22-81%,
respectively, when the initial EO amount was 0.25–1 w/w CS. whereas, the LC% of CS/PO NPs
and CS/GTO NPs were about 8-22% and 2.2-23%, respectively for the initial EO amount was
0.25–1 w/w. Furthermore, in-vitro release studies of both EOs showed an initial burst effect and
followed by a slow release at two different pH conditions: acidic pH (acetate buffer) and neutral
pH (phosphate buffer saline). Release rate of both PO and GTO from CS NPs was higher in
acetate buffer than phosphate buffer saline. PO was released over 92 hrs reaching of 63% in
acetate buffer and 62% in case of phosphate buffer saline. Both PO and GTO showed a thermal
stability after encapsulation in CS NPs that reach 350 . The antioxidant activity of both pure
and encapsulated PO and GTO was evaluated by 2,2-diphenyl-1-picrylhydrazyl radical (DPPH).
The antioxidant activities of CS/PO NPs and CS/GTO NPs were improved by about 2 and 2.4
folds, respectively. Moreover, to study the stability of total phenolic contents (TPC), Folin–
Ciocalteu was used and the results showed the ability of CS-TPP system to preserve the TPC.
Finally, agar dilution and colony counting method used to study the antibacterial activity of pure
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and encapsulated PO and GTO against Gram positive (S. aureus) and Gram negative (E.coli)
bacteria. Against (S. aureus), encapsulated PO showed an enhanced antibacterial activity by
about 39.63%, while encapsulated GTO showed an improvement in antibacterial activity by
about 57.5% on the other hand, against Gram negative bacteria, encapsulated PO showed an
enhanced antibacterial activity by about 3%, while encapsulated GTO showed an improvement
in antibacterial activity by about 1.8%.
The study showed that the encapsulation of PO and GTO in CS NPs could protect phenolic
contents of PO and GTO, enhance the thermal stability of EOs, improve the antioxidant activity,
and improve the antimicrobial activity. Based on these results, the encapsulating of PO and GTO
in CS NPs are promising candidates to be used in nutraceutical, cosmetic and pharmaceutical
applications.
Further research might be necessary to determine the stability of the EOs properties after
encapsulation process with CS NPs under different conditions. For examples, other EOs could be
used following the same protocols. In addition, different strains of bacteria could also be
investigated. Moreover, different forms of EOs such as nanofibers instead of NPs forms could be
fabricated to investigate the influence of the nanostructures on the final antioxidant and
antibacterial activities.
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Chapter 6: Appendices
Appendix I: GC/MS/MS analysis of PO.

Figure 60: GC/MS/MS chromatogram of PO.
Table 9: Chemical composition of PO.
Peak number Retention time

Chemical constituent

Relative concentration (%)

1

8.02

Glycerol trimethyl ether

14.62

2

8.289

Hexylene glycol

14.96

3

9.877

l-Menthone

14.55

4

10.012

Tetrahydrocarvone

6.55

5

10.142

Menthol

6.61

6

10.268

Citronellol

36.21

7

10.549

α-Terpineol

1.82

8

11.14

Pulegone

1.87

9

11.914

Levomenthol

2.8
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Appendix II: GC/MS/MS analysis of GTO.

Figure 61: GC/MS/MS chromatogram of GTO.

Table 10:Chemical composition of GTO.
Peak number Retention time Chemical constituent Relative concentration (%)
1
2
3
4
5
6
7
8
9
10
11

8.285
9.637
11.499
14.122
14.415
14.631
15.421
16.089
16.472
16.819
18.472

D-Limonene
Camphene
Linalyl acetate
Caryophyllene
Vitamin A aldehyde
α-Vetivol
4-Chromanol
Oleic alcohol
Curcumenol
β-Irone
Galaxolide 1
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2.9
1.99
2.91
0.89
0.77
3.57
54.89
25.08
2.02
1.1
3.9

Appendix III: Polydispersity of nanoparticles
To study the size distribution of NPs, the PDI was studied using DLS technique (zetasizer). As
shown in Figure (62), CS NP showed PDI of 0.24. Upon introducing PO to CS-TPP system in
different concentrations (0.25, 0.50, 0.75 and 1.00 (w/w CS)), results showed PDI values of
(0.23, 0.24, 0.22, 0.23 and 0.25) respectively, indicating that increasing the PO content had a
non-significant impact on the PDI value. The lowest PDI was that showing a higher
monodispersity in dispersion which occurred with CS/PO (1:0.75 w/w). On the other hand,
addition of GTO to CS-TPP system resulted in PDI values of (0.24, 0.24, 0.25, 0.24 and 0.25) in
concentrations of (0.25, 0.50, 0.75 and 1.00 (w/w CS) respectively. Similarly, incorporation of
GTO to CS NPs had a non-significant impact on the PDI value. The lowest PDI was that
showing a higher monodispersity in dispersion that occurred with CS/GTO (1:0.0.50 w/w). The
difference in PDI between both EOs with different concentrations were insignificant revealing
the independency of CS NP size distribution on the type of EO.

Figure 62:PDI values of nanoparticles as a function of initial PO and GTO content.
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